Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________

FORM 10-Q

___________________________________


(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For transition period from to
Commission File Number 001-36773

___________________________________

WORKIVA INC.

(Exact name of registrant as specified in its charter)

___________________________________


Delaware (State or other jurisdiction of incorporation or organization)									47-2509828 (I.R.S. Employer Identification Number)
2900 University Blvd Ames, IA 50010 (888) 275-3125
(Address of principal executive offices and zip code)
(888) 275-3125
(Registrant's telephone number, including area code)
___________________________________


Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol	Name of each exchange on which registered
Class A common stock, par value $.001	WK	New York Stock Exchange

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ý No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer ý			Accelerated filer o

Non-accelerated filer o			Smaller reporting company ☐

			Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No ý

As of October 24, 2023, there were approximately 50,202,454 shares of the registrant's Class A common stock and 3,845,583 shares of the registrant's Class B common stock outstanding.

WORKIVA INC.

TABLE OF CONTENTS


		Page
	Part I. Financial Information
Item 1.	Unaudited Consolidated Financial Statements:	1
	Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022	1
	Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2023 and 2022	3
	Condensed Consolidated Statements of Comprehensive Loss for the Three and Nine Months Ended September 30, 2023 and 2022	4
	Consolidated Statements of Changes in Stockholders' Equity (Deficit) for the Three and Nine Months Ended September 30, 2023 and 2022	5
	Condensed Consolidated Statements of Cash Flows for the Three and Nine Months Ended September 30, 2023 and 2022	7
	Notes to Condensed Consolidated Financial Statements	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosure About Market Risk	37
Item 4.	Controls and Procedures	37

	Part II. Other Information
Item 1.	Legal Proceedings	38
Item 1A.	Risk Factors	38
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	38
Item 6.	Exhibits	40
	Signatures	S-1

Table of Contents

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements in this Quarterly Report on Form 10-Q are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical facts, including statements regarding our future results of operations and financial position, our business strategy and plans and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2022, in “Item 1A. Risk Factors” in Part II of this Quarterly Report on Form 10-Q and in any subsequent filing we make with the SEC, as well as in any documents incorporated by reference that describe risks and factors that could cause results to differ materially from those projected in these forward-looking statements.

Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, achievements or events and circumstances reflected in the forward-looking statements will occur. We are under no duty to update any of these forward-looking statements after completion of this Quarterly Report on Form 10-Q to conform these statements to actual results or revised expectations.

Table of Contents

Part I. Financial Information

Item 1. Financial Statements


WORKIVA INC. CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
	As of September 30, 2023		As of December 31, 2022
	(unaudited)
ASSETS
Current assets
Cash and cash equivalents	$	404,885	$	240,197
Marketable securities	377,533		190,595
Accounts receivable, net of allowance for doubtful accounts of $801 and $744 at September 30, 2023 and December 31, 2022, respectively	98,861		106,316
Deferred costs	36,953		38,350
Other receivables	7,017		6,674
Prepaid expenses and other	21,902		17,957
Total current assets	947,151		600,089

Property and equipment, net	25,102		27,096
Operating lease right-of-use assets	10,228		13,932
Deferred costs, non-current	28,816		33,682
Goodwill	108,851		109,740
Intangible assets, net	23,585		28,234
Other assets	5,395		6,847
Total assets	$	1,149,128	$	819,620

Table of Contents


WORKIVA INC. CONDENSED CONSOLIDATED BALANCE SHEETS (continued)
(in thousands, except share and per share amounts)

	As of September 30, 2023		As of December 31, 2022
	(unaudited)
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities
Accounts payable	$	4,909	$	6,174
Accrued expenses and other current liabilities	94,158		83,999
Deferred revenue	338,418		316,263

Finance lease obligations	525		504
Total current liabilities	438,010		406,940

Convertible senior notes, non-current	761,847		340,257
Deferred revenue, non-current	38,216		38,237
Other long-term liabilities	1,539		1,518
Operating lease liabilities, non-current	9,023		12,102
Finance lease obligations, non-current	14,186		14,583
Total liabilities	1,262,821		813,637

Stockholders’ (deficit) equity
Class A common stock, $0.001 par value per share, 1,000,000,000 shares authorized, 50,173,423 and 48,761,804 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	50		49
Class B common stock, $0.001 par value per share, 500,000,000 shares authorized, 3,845,583 and 3,890,583 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	4		4
Preferred stock, $0.001 par value per share, 100,000,000 shares authorized, no shares issued and outstanding	—		—
Additional paid-in-capital	541,093		537,732
Accumulated deficit	(648,445)		(525,116)
Accumulated other comprehensive loss	(6,395)		(6,686)
Total stockholders’ (deficit) equity	(113,693)		5,983
Total liabilities and stockholders’ (deficit) equity	$	1,149,128	$	819,620

See accompanying notes.

Table of Contents


WORKIVA INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share and per share amounts) (unaudited)
	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Revenue
Subscription and support	$	143,421	$	118,591	$	409,857	$	339,064
Professional services	14,754		14,258		53,529		55,008
Total revenue	158,175		132,849		463,386		394,072
Cost of revenue
Subscription and support	24,864		19,235		74,080		56,683
Professional services	13,491		13,184		42,297		38,846
Total cost of revenue	38,355		32,419		116,377		95,529
Gross profit	119,820		100,430		347,009		298,543
Operating expenses
Research and development	41,747		38,583		130,235		113,644
Sales and marketing	72,576		64,560		215,168		184,879
General and administrative	21,022		27,405		86,660		75,507
Total operating expenses	135,345		130,548		432,063		374,030
Loss from operations	(15,525)		(30,118)		(85,054)		(75,487)
Interest income	7,294		1,440		15,546		2,325
Interest expense	(47,437)		(1,510)		(50,437)		(4,540)
Other (expense) income, net	(71)		964		(1,450)		1,467
Loss before provision for income taxes	(55,739)		(29,224)		(121,395)		(76,235)
Provision for income taxes	530		467		1,934		810
Net loss	$	(56,269)	$	(29,691)	$	(123,329)	$	(77,045)
Net loss per common share:
Basic and diluted	$	(1.04)	$	(0.56)	$	(2.28)	$	(1.46)
Weighted-average common shares outstanding - basic and diluted	54,256,941		53,081,564		53,987,791		52,844,532

See accompanying notes.

Table of Contents


WORKIVA INC. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (in thousands) (unaudited)
	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Net loss	$	(56,269)	$	(29,691)	$	(123,329)	$	(77,045)
Other comprehensive (loss) income
Foreign currency translation adjustment	(3,189)		(7,256)		(1,180)		(13,344)
Unrealized gain (loss) on available-for-sale securities	208		(619)		1,471		(3,033)
Other comprehensive (loss) income	(2,981)		(7,875)		291		(16,377)
Comprehensive loss	$	(59,250)	$	(37,566)	$	(123,038)	$	(93,422)

See accompanying notes.

Table of Contents


WORKIVA INC. CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)
(in thousands) (unaudited)

Nine Months Ended September 30, 2023
	Common Stock (Class A and B)
	Shares	Amount		Additional Paid-in-Capital		Accumulated Other Comprehensive Loss		Accumulated Deficit		Total Stockholders' Equity (Deficit)
Balances at December 31, 2022	52,652	$	53	$	537,732	$	(6,686)	$	(525,116)	$	5,983
Stock-based compensation expense	—	—		38,042		—		—		38,042
Issuance of common stock upon exercise of stock options	102	—		1,457		—		—		1,457
Issuance of common stock under employee stock purchase plan	107	—		5,546		—		—		5,546
Issuance of restricted stock units	449	—		—		—		—		—
Tax withholding related to net share settlements of stock-based compensation awards	(78)	—		(7,228)		—		—		(7,228)
Net loss	—	—		—		—		(46,150)		(46,150)
Other comprehensive income	—	—		—		3,280		—		3,280
Balances at March 31, 2023	53,232	$	53	$	575,549	$	(3,406)	$	(571,266)	$	930
Stock-based compensation expense	—	—		20,610		—		—		20,610
Issuance of common stock upon exercise of stock options	47	1		746		—		—		747
Issuance of restricted stock units	266	—		—		—		—		—
Tax withholding related to net share settlements of stock-based compensation awards	(12)	—		(1,212)		—		—		(1,212)
Net loss	—	—		—		—		(20,910)		(20,910)
Other comprehensive loss	—	—		—		(8)		—		(8)
Balances at June 30, 2023	53,533	$	54	$	595,693	$	(3,414)	$	(592,176)	$	157
Stock-based compensation expense	—	—		19,377		—		—		19,377
Issuance of common stock upon exercise of stock options	70	—		1,120		—		—		1,120
Issuance of common stock under employee stock purchase plan	93	—		6,967		—		—		6,967
Issuance of restricted stock units	332	—		—		—		—		—
Tax withholding related to net share settlements of stock-based compensation awards	(9)	—		(984)		—		—		(984)
Induced conversion of convertible senior notes	—	—		(81,080)		—		—		(81,080)
Net loss	—	—		—		—		(56,269)		(56,269)
Other comprehensive loss	—	—		—		(2,981)		—		(2,981)
Balances at September 30, 2023	54,019	$	54	$	541,093	$	(6,395)	$	(648,445)	$	(113,693)

Table of Contents


WORKIVA INC. CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (continued)
(in thousands) (unaudited)

Nine Months Ended September 30, 2022
	Common Stock (Class A and B)
	Shares	Amount		Additional Paid-in-Capital		Accumulated Other Comprehensive Loss		Accumulated Deficit		Total Stockholders' Equity (Deficit)
Balances at December 31, 2021	51,444	$	51	$	525,646	$	(288)	$	(452,430)	$	72,979
Stock-based compensation expense	—	—		15,309		—		—		15,309
Issuance of common stock upon exercise of stock options	62	1		824		—		—		825
Issuance of common stock under employee stock purchase plan	53	—		5,218		—		—		5,218
Issuance of restricted stock units	545	—		—		—		—		—
Tax withholding related to net share settlements of stock-based compensation awards	(73)	—		(8,570)		—		—		(8,570)
Adoption of ASU 2020-06	—	—		(58,560)		—		18,261		(40,299)
Net loss	—	—		—		—		(18,493)		(18,493)
Other comprehensive loss	—	—		—		(1,776)		—		(1,776)
Balances at March 31, 2022	52,031	$	52	$	479,867	$	(2,064)	$	(452,662)	$	25,193
Stock-based compensation expense	—	—		18,447		—		—		18,447
Issuance of common stock upon exercise of stock options	76	—		1,145		—		—		1,145
Issuance of restricted stock units	144	—		—		—		—		—
Tax withholding related to net share settlements of stock-based compensation awards	(12)	—		(1,344)		—		—		(1,344)
Net loss	—	—		—		—		(28,861)		(28,861)
Other comprehensive loss	—	—		—		(6,726)		—		(6,726)
Balances at June 30, 2022	52,239	$	52	$	498,115	$	(8,790)	$	(481,523)	$	7,854
Stock-based compensation expense	—	—		20,297		—		—		20,297
Issuance of common stock upon exercise of stock options	43	—		625		—		—		625
Issuance of common stock under employee stock purchase plan	79	1		4,037		—		—		4,038
Issuance of restricted stock units	145	—		—		—		—		—
Tax withholding related to net share settlements of stock-based compensation awards	(11)	—		(738)		—		—		(738)
Net loss	—	—		—		—		(29,691)		(29,691)
Other comprehensive loss	—	—		—		(7,875)		—		(7,875)
Balances at September 30, 2022	52,495	$	53	$	522,336	$	(16,665)	$	(511,214)	$	(5,490)

See accompanying notes.

Table of Contents


WORKIVA INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands) (unaudited)
	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Cash flows from operating activities
Net loss	$	(56,269)	$	(29,691)	$	(123,329)	$	(77,045)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	2,686		2,681		8,353		7,365
Stock-based compensation expense	19,377		20,297		78,029		54,053
Provision for doubtful accounts	8		91		57		82
Realized loss on sale of available-for-sale securities, net	—		—		708		—
(Accretion) amortization of premiums and discounts on marketable securities, net	(1,930)		129		(4,530)		1,242

Amortization of issuance costs and debt discount	472		325		1,122		973
Induced conversion expense	45,144		—		45,144		—
Deferred income tax	(14)		57		(17)		(91)
Changes in assets and liabilities:
Accounts receivable	(15,234)		(7,927)		7,243		(6,190)
Deferred costs	3,116		(1,372)		6,248		(2,662)
Operating lease right-of-use asset	1,244		1,269		3,807		3,877
Other receivables	(1,556)		(527)		(1,842)		38
Prepaid expenses and other	3,452		3,593		(3,985)		870
Other assets	1,043		(1,140)		1,479		(1,105)
Accounts payable	(386)		3,931		(1,267)		5,995
Deferred revenue	11,120		14,775		22,225		28,573
Operating lease liability	(750)		(1,113)		(3,129)		(3,757)
Accrued expenses and other liabilities	3,468		(523)		10,217		384
Net cash provided by operating activities	14,991		4,855		46,533		12,602

Cash flows from investing activities
Purchase of property and equipment	(895)		(1,023)		(1,732)		(2,226)
Purchase of marketable securities	(144,989)		(41,618)		(322,008)		(99,564)
Sale of marketable securities	—		—		65,052		14,981
Maturities of marketable securities	36,906		40,071		76,811		106,857
Acquisitions, net of cash acquired	—		—		—		(99,186)
Purchase of intangible assets	(48)		(62)		(167)		(108)

Net cash used in investing activities	(109,026)		(2,632)		(182,044)		(79,246)

Table of Contents


WORKIVA INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
(in thousands) (unaudited)
	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022

Cash flows from financing activities
Proceeds from option exercises	1,120		625		3,324		2,595
Taxes paid related to net share settlements of stock-based compensation awards	(984)		(738)		(9,424)		(10,652)
Proceeds from shares issued in connection with employee stock purchase plan	6,967		4,038		12,513		9,256
Proceeds from the issuance of convertible senior notes, net of issuance costs	691,113		—		691,113		—
Payments for repurchase of convertible senior notes	(396,869)		—		(396,869)		—
Principal payments on finance lease obligations	(127)		(454)		(376)		(1,342)

Net cash provided by (used in) financing activities	301,220		3,471		300,281		(143)
Effect of foreign exchange rates on cash	(1,239)		(2,450)		(82)		(4,102)

Net increase (decrease) in cash and cash equivalents	205,946		3,244		164,688		(70,889)
Cash and cash equivalents at beginning of period	198,939		226,253		240,197		300,386
Cash and cash equivalents at end of period	$	404,885	$	229,497	$	404,885	$	229,497

Supplemental cash flow disclosure
Cash paid for interest	$	2,160	$	2,152	$	4,509	$	4,535
Cash paid for income taxes, net of refunds	$	604	$	225	$	2,126	$	852

See accompanying notes.

Table of Contents

WORKIVA INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Organization and Significant Accounting Policies

Organization

Workiva Inc., a Delaware corporation, and its wholly-owned subsidiaries (the “Company” or “we” or “us”) is on a mission to power transparent reporting for a better world. We believe that consumers, employees, shareholders, and other stakeholders today expect more from business – more action, transparency, and disclosure of financial and non-financial information. We build solutions to meet that demand and streamline processes, connect data and teams, and ensure consistency – all within the Workiva platform, the world’s leading cloud platform for assured integrated reporting. Our operational headquarters are located in Ames, Iowa, with additional offices located in the United States, Europe, the Asia-Pacific region and Canada.

Basis of Presentation and Principles of Consolidation

The financial information presented in the accompanying unaudited condensed consolidated financial statements has been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated balance sheet data as of December 31, 2022 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting primarily of normal recurring accruals, necessary for a fair presentation of our financial position and results of operations. The operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results expected for the full year ending December 31, 2023.

Seasonality affects our revenue, expenses and cash flows from operations. Revenue from professional services has been higher in the first quarter as many of our customers file their 10-K in the first calendar quarter. Our sales and marketing expense also has some degree of seasonality. With the exception of September 2020 and September 2021 when we transitioned to a virtual event, sales and marketing expense has historically been higher in the third quarter due to our annual user conference in September. In addition, the timing of the payments of cash bonuses to employees during the first and fourth calendar quarters may result in some seasonality in operating cash flow. The condensed consolidated financial information should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in this report and the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on February 21, 2023.

The unaudited condensed consolidated financial statements include the accounts of Workiva Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Table of Contents

Use of Estimates

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions believed to be reasonable. These estimates include, but are not limited to, the allowance for doubtful accounts, the determination of the relative selling prices of our services, the measurement of material rights, health insurance claims incurred but not yet reported, valuation of available-for-sale marketable securities, useful lives of deferred contract costs, intangible assets and property and equipment, goodwill, income taxes, discount rates used in the valuation of right-of-use assets and lease liabilities, and certain assumptions used in the valuation of equity awards. While these estimates are based on our best knowledge of current events and actions that may affect us in the future, actual results may differ materially from these estimates.

Recently Adopted Accounting Pronouncements

None.

New Accounting Pronouncements Not Yet Adopted

None.

2. Supplemental Consolidated Balance Sheet Information

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	As of September 30, 2023		As of December 31, 2022
Accrued vacation	$	15,551	$	12,939
Accrued commissions	6,083		10,841
Accrued bonuses	21,796		5,597
Accrued payroll	5,181		5,318
Estimated health insurance claims	2,573		1,841
Accrued interest	1,116		1,455
ESPP employee contributions	4,163		5,661
Customer deposits	24,932		25,520
Operating lease liabilities	4,463		5,720
Accrued other liabilities	8,300		9,107
	$	94,158	$	83,999

Table of Contents

3. Cash Equivalents and Marketable Securities

At September 30, 2023, cash equivalents and marketable securities consisted of the following (in thousands):


	Amortized Cost		Unrealized Gains		Unrealized Losses		Aggregate Fair Value
Money market funds	$	260,895	$	—	$	—	$	260,895
Commercial paper	72,852		—		—		72,852
U.S. treasury debt securities	157,080		7		(305)		156,782
U.S. government agency debt securities	61,190		—		(118)		61,072
Corporate debt securities	125,397		2		(728)		124,671
Foreign government debt securities	997		—		(16)		981
	$	678,411	$	9	$	(1,167)	$	677,253
Included in cash and cash equivalents	$	299,720	$	—	$	—	$	299,720
Included in marketable securities	$	378,691	$	9	$	(1,167)	$	377,533

At December 31, 2022, cash equivalents and marketable securities consisted of the following (in thousands):


	Amortized Cost		Unrealized Gains		Unrealized Losses		Aggregate Fair Value
Money market funds	$	182,878	$	—	$	—	$	182,878

U.S. treasury debt securities	72,151		1		(899)		71,253
Corporate debt securities	120,081		62		(1,771)		118,372
Foreign government debt securities	993		—		(23)		970
	$	376,103	$	63	$	(2,693)	$	373,473
Included in cash and cash equivalents	$	182,878	$	—	$	—	$	182,878
Included in marketable securities	$	193,225	$	63	$	(2,693)	$	190,595

The contractual maturities of the investments classified as marketable securities are as follows (in thousands):


	As of September 30, 2023
Due within one year	$	250,767
Due in one to two years	126,766

	$	377,533

The following table presents gross unrealized losses and fair values for those cash equivalents and marketable securities that were in an unrealized loss position as of September 30, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in thousands):

Table of Contents


	As of September 30, 2023
	Less than 12 months				12 months or greater
	Fair Value		Unrealized Loss		Fair Value		Unrealized Loss
U.S. treasury debt securities	$	90,224	$	(230)	$	6,567	$	(76)
U.S. government agency debt securities	61,072		(118)		—		—
Corporate debt securities	90,732		(463)		27,945		(264)
Foreign government debt securities	—		—		981		(16)
Total	$	242,028	$	(811)	$	35,493	$	(356)

We do not believe the unrealized losses represent credit losses based on our evaluation of available evidence as of September 30, 2023, which includes an assessment of whether it is more likely than not we will be required to sell the investment before recovery of the investment's amortized cost basis.

4. Fair Value Measurements

We determine the fair values of our financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value:

Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2 - Inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.

Level 3 - Inputs are unobservable inputs based on our assumptions.

Table of Contents

Financial Assets

Cash equivalents primarily consist of AAA-rated money market funds with overnight liquidity and no stated maturities. We classified cash equivalents as Level 1 due to the short-term nature of these instruments and measured the fair value based on quoted prices in active markets for identical assets.

When available, our marketable securities are valued using quoted prices for identical instruments in active markets. If we are unable to value our marketable securities using quoted prices for identical instruments in active markets, we value our investments using broker reports that utilize quoted market prices for comparable instruments. We validate, on a sample basis, the derived prices provided by the brokers by comparing their assessment of the fair values of our investments against the fair values of the portfolio balances of another third-party professional pricing service. As of September 30, 2023, all of our marketable securities were valued using quoted prices for comparable instruments in active markets and are classified as Level 2.

Based on our valuation of our money market funds and marketable securities, we concluded that they are classified in either Level 1 or Level 2, and we have no financial assets measured using Level 3 inputs on a recurring basis. The following table presents information about our assets that are measured at fair value on a recurring basis using the above input categories (in thousands):


	Fair Value Measurements as of September 30, 2023						Fair Value Measurements as of December 31, 2022
Description	Total		Level 1		Level 2		Total		Level 1		Level 2
Money market funds	$	260,895	$	260,895	$	—	$	182,878	$	182,878	$	—
Commercial paper	72,852		—		72,852		—		—		—
U.S. treasury debt securities	156,782		—		156,782		71,253		—		71,253
U.S. government agency debt securities	61,072		—		61,072		—		—		—
Corporate debt securities	124,671		—		124,671		118,372		—		118,372
Foreign government debt securities	981		—		981		970		—		970
	$	677,253	$	260,895	$	416,358	$	373,473	$	182,878	$	190,595

Included in cash and cash equivalents	$	299,720					$	182,878
Included in marketable securities	$	377,533					$	190,595

Convertible Senior Notes

As of September 30, 2023, the fair value of our convertible senior notes due in 2026 and 2028 was $97.7 million and $689.7 million, respectively. The fair value was determined based on the quoted price of the convertible senior notes in an over-the-counter market on the last trading day of the reporting period and has been classified as Level 2 in the fair value hierarchy. See Note 5 to the condensed consolidated financial statements for more information.

Table of Contents

5. Convertible Senior Notes

The following table presents details of our convertible senior notes, which are further discussed below (original principal in thousands):

Month Issued

Maturity Date

Free Convertibility Date

Redemption Date

Original Principal (including overallotment)

Initial Conversion Rate per $1,000 Principal

Initial Conversion Price

2026 Notes

August 2019

August 15, 2026

May 15, 2026

August 21, 2023

345,000

12.4756

80.16

2028 Notes

August 2023

August 15, 2028

May 15, 2028

August 21, 2026

702,000

7.4690

133.89

In August 2019, we issued $345.0 million aggregate principal amount of 1.125% convertible senior notes due 2026 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, including the exercise in full by the initial purchasers of their option to purchase an additional $45.0 million principal amount (the "2026 Notes”). The 2026 Notes bear interest at a fixed rate of 1.125% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, commencing on February 15, 2020. Proceeds from the issuance of the 2026 Notes totaled $335.9 million, net of initial purchaser discounts and issuance costs.

In August 2023, we issued $702.0 million aggregate principal amount of 1.250% convertible senior notes due 2028 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, including the partial exercise of 77.0 million principal amount by the initial purchasers of their option to purchase up to an additional $100 million principal amount (the "2028 Notes”). The 2028 Notes bear interest at a fixed rate of 1.250% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, commencing on February 15, 2024. Proceeds from the issuance of the 2028 Notes totaled $691.1 million, net of initial purchaser discounts and issuance costs.

The 2026 Notes and the 2028 Notes are together referred to as the "Notes".

The Notes were issued pursuant to an indenture and are senior, unsecured obligations of the Company. The 2028 Notes will rank equally with all of the Company’s existing and future senior unsecured indebtedness, including the Company’s outstanding 2026 Notes.

Holders of the Notes may convert all or a portion of their Notes prior to the close of business on their respective Free Convertibility dates, in multiples of $1,000 principal amount, only under the following circumstances:

•during any calendar quarter commencing after the calendar quarter in which the respective Notes were issued (and only during such calendar quarter), if the last reported sale price of our Class A common stock, par value $0.001 per share (which we refer to in this offering memorandum as our “Class A common stock”), for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

•during the five consecutive business day period immediately following any ten consecutive trading day period (the “measurement period”) in which the trading price (as defined below) per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our Class A common stock and the conversion rate on each such trading day;

Table of Contents

•if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

•upon the occurrence of certain specified corporate events as set forth in the relevant indenture.

On or after the relevant Free Convertibility Date, holders of the Notes may convert their Notes at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the Notes.

Upon conversion, we will pay or deliver, as the case may be, cash, shares of our Class A common stock or a combination of cash and shares of our Class A common stock, at our election, in the manner and subject to the terms and conditions provided in the indenture.

The Company may redeem for cash all or any portion of the Notes, at its option, on or after the respective Redemption Date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus any accrued and unpaid interest to, but excluding, the respective Redemption Date.

During the third quarter of 2023 none of the conversion conditions were met and therefore the Notes are not convertible at the option of the holders. As a result, the Notes were classified as non-current liabilities on the condensed consolidated balance sheet as of September 30, 2023.

Interest expense representing the amortization of issuance costs as well as contractual interest expense is amortized to interest expense at an effective interest rate of 1.5% and 1.6% over the term of the 2026 Notes and 2028 Notes, respectively.

As of September 30, 2023, the remaining life of the 2026 Notes and 2028 Notes were approximately 2.8 years and 4.9 years.

Partial Repurchase of 2026 Notes

We used $396.9 million of the net proceeds from the 2028 Notes offering discussed above to repurchase $273.8 million principal amount, together with accrued and unpaid interest thereon, of our 2026 Notes in separate and individually negotiated transactions with certain holders. The repurchase was accounted for as an induced conversion. The fair value of the repurchased 2026 Notes on the date of repurchase was $351.8 million. The consideration in excess of fair value resulted in a loss on induced conversion of $45.1 million which was recorded as interest expense in the condensed consolidated statement of operations. The difference between the fair value and the carrying value of the 2026 Notes on the date of repurchase of $81.1 million, including unamortized debt issuance costs of $3.1 million, was recorded in additional paid-in capital.

The net carrying amount of the Notes was as follows (in thousands):


	September 30, 2023				December 31, 2022
	2026 Notes		2028 Notes		2026 Notes		2028 Notes
Principal	$	71,242	$	702,000	$	345,000	$	—
Unamortized issuance costs	(778)		(10,617)		(4,743)		—
Net carrying amount	$	70,464	$	691,383	$	340,257	$	—

Table of Contents

Interest expense related to the Notes was as follows (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Contractual interest expense	$	1,618	$	970	$	3,558	$	2,910
Amortization of issuance costs	472		325		1,122		973
Total interest expense	$	2,090	$	1,295	$	4,680	$	3,883

6. Commitments and Contingencies

Litigation

From time to time we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We evaluate the development of legal matters on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Although the results of litigation and claims cannot be predicted with certainty, we currently believe that the final outcome of any currently pending legal proceedings to which we are a party will not have a material adverse effect on our business, operating results, financial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

7. Stock-Based Compensation

We grant stock-based incentive awards to attract, motivate and retain qualified employees, non-employee directors and consultants, and to align their financial interests with those of our stockholders. We utilize stock-based compensation in the form of restricted stock units, performance restricted stock units, options to purchase Class A common stock and Employee Stock Purchase Plan ("ESPP") purchase rights. Prior to our corporate conversion in December 2014, awards were provided under the 2009 Unit Incentive Plan (“the 2009 Plan”). The 2009 Plan was amended to provide that no further awards will be issued thereunder, and our board of directors and stockholders adopted and approved our 2014 Equity Incentive Plan (“the 2014 Plan” and, together with the 2009 Plan, “the Plans”).

Stock-Based Compensation Expense

Stock-based compensation expense was recorded in the following cost and expense categories consistent with the respective employee or service provider’s related cash compensation (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Cost of revenue
Subscription and support	$	1,247	$	855	$	3,732	$	2,557
Professional services	623		533		1,923		1,578
Operating expenses
Research and development	4,155		3,399		13,677		9,272
Sales and marketing	7,108		4,657		20,769		14,388
General and administrative	6,244		10,853		37,928		26,258
Total	$	19,377	$	20,297	$	78,029	$	54,053

Table of Contents

During the first nine months of 2023, we recognized an additional $18.1 million in stock-based compensation pursuant to certain transition agreements with former executives who retired during the period.

Stock Options

The following table summarizes the option activity under the Plans for the nine months ended September 30, 2023:


	Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)

Outstanding at December 31, 2022	1,509,172	$	14.57	3.2
Granted	—	—
Forfeited	(10)	13.60
Expired	—	—
Exercised	(219,354)	15.16
Outstanding at September 30, 2023	1,289,808	$	14.47	2.5

Exercisable at September 30, 2023	1,289,808	$	14.47	2.5

Restricted Stock Units and Performance Restricted Stock Units

The following table summarizes the restricted stock unit and performance restricted stock unit activity under the Plans for the nine months ended September 30, 2023:


	Number of Shares	Weighted- Average Grant Date Fair Value

Unvested at December 31, 2022	1,921,927	$	93.80
Granted	1,148,206	94.70
Forfeited	(106,570)	92.53
Vested(1)	(689,844)	86.47
Unvested at September 30, 2023	2,273,719	$	96.51

(1) During the nine months ended September 30, 2023, in accordance with our Nonqualified Deferred Compensation Plan, recipients elected to defer settlement of 2,925 shares of their vested restricted stock units and 359,812 shares were released from deferral.

Employee Stock Purchase Plan

During the nine months ended September 30, 2023, 200,436 shares of common stock were purchased under the ESPP at a weighted-average price of $62.43 per share, resulting in cash proceeds of $12.5 million.

Compensation expense associated with ESPP purchase rights is recognized on a straight-line basis over the vesting period. At September 30, 2023, there was approximately $1.3 million of total unrecognized compensation expense related to the ESPP, which is expected to be recognized over a weighted-average period of 0.3 years.

Table of Contents

8. Revenue Recognition

Disaggregation of Revenue

Revenues by industry are derived from leading software providers. The following table presents our revenues disaggregated by industry (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Industrials	$	23,461	$	18,810	$	68,670	$	56,398
Diversified financials	22,927		17,472		66,916		51,864
Information technology	17,041		15,283		50,925		45,418
Banks	15,951		13,871		46,554		39,943
Consumer discretionary	15,224		13,301		44,511		38,147
Healthcare	13,549		11,701		39,949		35,158
Insurance	9,725		8,161		28,031		23,683
Real estate	6,600		5,647		19,765		17,651
Energy	6,618		5,577		19,883		17,169
Utilities	5,854		5,383		17,165		16,800
Materials	5,852		5,121		17,391		15,954
Public administration	4,886		3,844		13,754		11,046
Consumer staples	4,557		4,213		13,544		12,626
Telecommunication services	4,449		3,262		12,352		9,724
Other	1,481		1,203		3,976		2,491
Total revenues	$	158,175	$	132,849	$	463,386	$	394,072

The following table presents our revenues disaggregated by type of good or service (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Subscription and support	$	143,421	$	118,591	$	409,857	$	339,064
XBRL professional services	11,555		10,634		42,719		41,844
Other services	3,199		3,624		10,810		13,164
Total revenues	$	158,175	$	132,849	$	463,386	$	394,072

Deferred Revenue

We recognized $129.9 million and $107.7 million of revenue during the three months ended September 30, 2023 and 2022, respectively, that was included in the deferred revenue balances at the beginning of the respective periods. We recognized $277.8 million and $224.6 million of revenue during the nine months ended September 30, 2023 and 2022, respectively, that was included in the deferred revenue balances at the beginning of the respective periods.

Table of Contents

Transaction Price Allocated to the Remaining Performance Obligations

As of September 30, 2023, we expect revenue of approximately $835.5 million to be recognized from remaining performance obligations for subscription contracts. We expect to recognize approximately $466.7 million of these remaining performance obligations over the next 12 months with the balance substantially recognized in the 24 months thereafter.

9. Net Loss Per Share

Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock, including convertible senior notes, outstanding stock options, stock related to unvested restricted stock units, and common stock issuable pursuant to the ESPP to the extent dilutive. Basic and diluted net loss per share was the same for each period presented, as the inclusion of all potential common shares outstanding would have been anti-dilutive.

The net loss per share is allocated based on the participation rights of the Class A and Class B common shares as if the loss for the year has been distributed. As the liquidation and dividend rights are identical, the net loss is allocated on a proportionate basis.

A reconciliation of the denominator used in the calculation of basic and diluted loss per share is as follows (in thousands, except share and per share data):


	Three months ended
	September 30, 2023				September 30, 2022
	Class A		Class B		Class A		Class B
Numerator
Net loss	$	(52,281)	$	(3,988)	$	(27,515)	$	(2,176)

Denominator
Weighted-average common shares outstanding - basic and diluted	50,411,358		3,845,583		49,190,981		3,890,583
Basic and diluted net loss per share	$	(1.04)	$	(1.04)	$	(0.56)	$	(0.56)


	Nine months ended
	September 30, 2023				September 30, 2022
	Class A		Class B		Class A		Class B
Numerator
Net loss	$	(114,522)	$	(8,807)	$	(71,310)	$	(5,735)

Denominator
Weighted-average common shares outstanding - basic and diluted	50,132,483		3,855,308		48,911,092		3,933,440
Basic and diluted net loss per share	$	(2.28)	$	(2.28)	$	(1.46)	$	(1.46)

Table of Contents

The anti-dilutive securities excluded from the weighted-average shares used to calculate the diluted net loss per common share were as follows:


	As of
	September 30, 2023	September 30, 2022
Shares subject to outstanding common stock options	1,289,808	1,566,858
Shares subject to unvested restricted stock units and performance restricted stock units	2,273,719	1,949,563
Shares issuable pursuant to the ESPP	86,000	115,715
Shares underlying our convertible senior notes	9,547,320	4,304,082

We use the if-converted method for calculating any potential dilutive effect of our convertible senior notes on diluted net income per share, if applicable.

10. Intangible Assets and Goodwill

The following table presents the components of net intangible assets (in thousands):


	As of September 30, 2023							As of December 31, 2022
	Weighted Average Useful Life (Years)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Acquired technology	4.5	$	15,613	$	(6,474)	$	9,139	$	15,705	$	(3,849)	$	11,856
Acquired customer-related	10.0	14,796		(2,284)		12,512		14,969		(1,169)		13,800
Acquired trade names	2.9	2,143		(1,506)		637		2,151		(861)		1,290
Patents	10.0	3,083		(1,786)		1,297		2,916		(1,628)		1,288
Total	7.1	$	35,635	$	(12,050)	$	23,585	$	35,741	$	(7,507)	$	28,234

Amortization expense related to intangible assets was $1.5 million during the three months ended September 30, 2023 and 2022, and $4.6 million and $3.8 million for the nine months ended September 30, 2023 and 2022, respectively.

As of September 30, 2023, expected remaining amortization expense of intangible assets by fiscal year is as follows (in thousands):


Remainder of 2023	$	1,520
2024	5,356
2025	4,623
2026	3,308
2027	2,040
Thereafter	6,738
Total expected amortization expense	$	23,585

Table of Contents

The changes in the carrying amount of goodwill were as follows (in thousands):


December 31, 2022	$	109,740

Foreign currency translation adjustments	(889)
September 30, 2023	$	108,851

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of our operations should be read in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this report and in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 21, 2023. In addition to historical consolidated financial information, this discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those discussed below. Factors that could cause or contribute to these differences include, but are not limited to, those identified below, and those discussed in “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2022, in “Item 1A. Risk Factors” in Part II of this Quarterly Report on Form 10-Q and in any subsequent filing we make with the SEC.

Overview

Workiva’s mission is to power transparent reporting for a better world. We believe that consumers, employees, shareholders, and other stakeholders today expect more from business – more action, transparency, and disclosure of financial and non-financial information. We build solutions to meet that demand and streamline processes, connect data and teams, and ensure consistency – all within the Workiva platform, the world’s leading cloud platform for assured integrated reporting. Additionally, we offer the only unified software-as-a-service (“SaaS”) platform that brings customers’ financial reporting, Environmental, Social, and Governance (“ESG”), and Governance, Risk, and Compliance (“GRC”) together in a controlled, secure, audit-ready platform.

The Workiva platform empowers customers by connecting and transforming data from hundreds of enterprise resource planning (“ERP”), human capital management (“HCM”), and customer relationship management (“CRM”) systems, as well as other third-party cloud and on-premise applications. Customers use our platform to create, review and publish data-linked documents and reports with greater control, consistency, accuracy, and productivity. Our platform is flexible and scalable, so customers can easily adapt it to define, automate, and change their business processes in real time.

Workiva provides more than 5,000 organizations across the globe with SaaS platform solutions to help solve some of the most complex reporting and disclosure challenges. While our customers use our platform for more than 100 different use cases, we organize our sales and marketing resources into four purpose-built solution groups focusing primarily on the office of the Chief Financial Officer (“CFO”): financial reporting, ESG, GRC, and industry verticals. Workiva also serves approximately 900 customers with non-platform, eXtensible Business Reporting Language ("XBRL")-tagging services, primarily through ParsePort, an XBRL conversion software company Workiva acquired in 2022.

We operate our business on a Software-as-a-Service (“SaaS”) model. Customers enter into annual and multi-year subscription contracts to gain access to our platform. Our subscription fee includes the use of our software and technical support. Our subscription pricing is based primarily on a solution-based licensing model. Under this model, operating metrics related to a customer’s expected use of each solution determine the price. We charge customers additional fees primarily for document setup and XBRL tagging services.

We generate sales primarily through our direct sales force and, to a lesser extent, our customer success and professional services teams. In addition, we augment our direct sales channel with partnerships. Our advisory and service partners offer a wider range of domain and functional expertise that broadens the capabilities of our platform, bringing scale and support to customers and prospects. Our technology partners enable more data and process integrations to help customers connect critical transactional systems directly to our platform.

Table of Contents

We continue to invest in the development of our solutions, infrastructure and sales and marketing to drive long-term growth. Our full-time employee headcount increased to 2,519 at September 30, 2023 from 2,446 at September 30, 2022, an increase of 3.0%.

We have achieved significant revenue growth in recent periods. Our revenue grew to $158.2 million and $463.4 million during the three and nine months ended September 30, 2023, respectively from $132.8 million and $394.1 million during the three and nine months ended September 30, 2022, respectively. We incurred a net loss of $56.3 million and $123.3 million during the three and nine months ended September 30, 2023, respectively compared to $29.7 million and $77.0 million during the three and nine months ended September 30, 2022, respectively.

We continue to invest for future growth and are focused on several key drivers, including focusing on multi-solution adoption by new and existing customers, further developing our partner program, accelerating international expansion and developing our fit-for-purpose solutions. These growth drivers often require a more sophisticated go-to-market approach and, as a result, we may incur additional costs upfront to obtain new customers and expand our relationships with existing customers, including additional sales and marketing expenses.

Effects of Volatility in the IPO/SPAC Markets

In the United States, volatility in the public markets led to a decrease in the number of initial public offerings (“IPOs”) and special-purpose acquisition companies (“SPACs”) in 2022. New sales of our SEC and capital markets solutions were adversely affected by this decline in the IPO and SPAC markets. Reduced valuation multiples caused by higher interest rates, inflation, and geopolitical instability continue to negatively impact the number of IPOs and SPACs in fiscal year 2023. Accordingly, this volatility continues to apply pressure to new sales of our SEC and capital markets solutions. Whether and to what extent the IPO and SPAC markets will moderate cannot be accurately predicted.

Key Factors Affecting Our Performance

Generate Growth From Existing Customers. The Workiva platform can exhibit a powerful network effect within an enterprise, meaning that the usefulness of our platform attracts additional users. Since solution-based licensing offers our customers an unlimited number of seats for each solution purchased, we expect customers to add more seats over time. As more employees in an enterprise use our platform, additional opportunities for collaboration and automation drive demand among their colleagues for additional solutions.

Pursue New Customers. We sell to organizations that manage large, complex processes with distributed teams of contributors and disparate sets of business data. We market our platform to professionals and executives in the areas of financial and non-financial reporting, including regulatory, multi-entity and performance reporting. In addition, we market to teams responsible for environmental, social and governance reporting, and governance, risk and compliance programs. We intend to continue to build our sales and marketing organization and leverage our brand equity to attract new customers.

Offer More Solutions. We intend to introduce new solutions to continue to meet growing demand for our platform. Our close and trusted relationships with our customers are a source for new use cases, features and solutions. We have a disciplined process for tracking, developing and releasing new solutions that are designed to have immediate, broad applicability; a strong value proposition; and a high return on investment for both Workiva and our customers. Our advance planning team assesses customer needs, conducts industry-based research and defines new markets. This vetting process involves our sales, product marketing, customer success, professional services, research and development, finance and senior management teams.

Table of Contents

Expand Across Enterprises. Our success in delivering multiple solutions has created demand from customers for a broader-based, enterprise-wide Workiva platform. In response, we have been improving our technology and realigning sales and marketing to capitalize on our growing enterprise-wide opportunities. We believe this expansion will add seats and revenue and continue to support our high revenue retention rates. However, we expect that enterprise-wide deals will be larger and more complex, which tend to lengthen the sales cycle.

Add Partners. We continue to expand and deepen our relationships with global and regional partners, including consulting firms, system integrators, large and mid-sized independent software vendors, and implementation partners. Our advisory and service partners offer a wider range of domain and functional expertise that broadens our platform’s capabilities and promotes Workiva as part of the digital transformation projects they drive for their customers. Our technology partners enable powerful data and process integrations to help customers connect critical transactional systems directly to our platform, with powerful linking, auditability and control features. We believe that our partner ecosystem extends our global reach, accelerates the usage and adoption of our platform, and enables more efficient delivery of professional services.

Investment in growth. We plan to continue to invest in the development of our platform, fit-for-purpose solutions and application marketplace to enhance our current offerings and build new features. In addition, we expect to continue to invest in our sales, marketing, professional services and customer success organizations to drive additional revenue and support the needs of our growing customer base and to take advantage of opportunities that we have identified in Europe, the Middle East and Africa ("EMEA") and Asia-Pacific ("APAC") regions.

Seasonality. Our revenue from professional services has some degree of seasonality. Many of our customers employ our professional services just before they file their Form 10-K, often in the first calendar quarter. Our sales and marketing expense also has some degree of seasonality. With the exception of September 2020 and September 2021 when we transitioned to a virtual event, sales and marketing expense has historically been higher in the third quarter due to our annual user conference in September. In addition, the timing of the payments of cash bonuses to employees during the first and fourth calendar quarters may result in some seasonality in operating cash flow.

Table of Contents

Key Performance Indicators


	Three months ended September 30,						Nine months ended September 30,
	2023			2022			2023			2022

	(dollars in thousands)
Financial metrics
Total revenue	$	158,175		$	132,849		$	463,386		$	394,072
Percentage increase in total revenue	19.1		%	17.9		%	17.6		%	22.2		%
Subscription and support revenue	$	143,421		$	118,591		$	409,857		$	339,064
Percentage increase in subscription and support revenue	20.9		%	19.9		%	20.9		%	23.3		%
Subscription and support as a percent of total revenue	90.7		%	89.3		%	88.4		%	86.0		%


	As of September 30,
	2023	2022
Operating metrics
Number of customers	5,945	5,541
Subscription and support revenue retention rate	97.7%	98.1%
Subscription and support revenue retention rate including add-ons	112.0%	107.0%
Number of customers with annual contract value $100k+	1,561	1,257
Number of customers with annual contract value $150k+	851	676
Number of customers with annual contract value $300k+	296	214

Total customers. We believe total number of customers is a key indicator of our financial success and future revenue potential. We define a customer as an entity with an active subscription contract as of the measurement date. Our customer is typically a parent company or, in a few cases, a significant subsidiary that works with us directly. Companies with publicly-listed securities account for a substantial majority of our customers. As of September 30, 2023 and 2022, our total customer count includes 926 and 895 ParsePort ESEF customers, respectively.

Subscription and support revenue retention rate. We calculate our subscription and support revenue retention rate based on all customers that were active at the end of the same calendar quarter of the prior year (“base customers”). We begin by annualizing the subscription and support revenue recorded in the same calendar quarter of the prior year for those base customers who are still active at the end of the current quarter. We divide the result by the annualized subscription and support revenue in the same quarter of the prior year for all base customers.

Our subscription and support revenue retention rate was 97.7% as of September 30, 2023, down slightly from 98.1% as of September 30, 2022. We believe that our success in maintaining a high rate of revenue retention is attributable primarily to our robust technology platform and strong customer service. Customers whose securities were deregistered due to merger or acquisition or financial distress accounted for just over half of our revenue attrition in the latest quarter.

Subscription and support revenue retention rate including add-ons. Add-on revenue includes the change in both solutions and pricing for existing customers. We calculate our subscription and support revenue retention rate including add-ons by annualizing the subscription and support revenue recorded in the current quarter for our base customers that were active at the end of the current quarter. We divide the

Table of Contents

result by the annualized subscription and support revenue in the same quarter of the prior year for all base customers.

Our subscription and support revenue retention rate including add-ons was 112.0% as of the quarter ended September 30, 2023, up from 107.0% as of September 30, 2022.

Annual contract value. Our annual contract value (“ACV”) for each customer is calculated by annualizing the subscription and support revenue recognized during each quarter. We believe the increase in the number of larger contracts shows our progress in expanding our customers’ adoption of our platform.


	Three months ended September 30,		Nine months ended September 30,
	2023	2022	2023	2022
Subscription and support revenue from customers with annual contract value of $100k+ as a percent of total subscription and support revenue	67.1%	62.3%	65.6%	61.6%
Subscription and support revenue from customers with annual contract value of $150k+ as a percent of total subscription and support revenue	52.1%	47.4%	51.0%	46.9%
Subscription and support revenue from customers with annual contract value of $300k+ as a percent of total subscription and support revenue	32.6%	27.6%	31.2%	27.1%

Components of Results of Operations

Revenue

We generate revenue through the sale of subscriptions to our cloud-based software and the delivery of professional services. We serve a wide range of customers in many industries, and our revenue is not concentrated with any single customer or small group of customers. For the nine months ended September 30, 2023 and 2022, no single customer represented more than 1% of our revenue, and our largest 10 customers accounted for less than 5% of our revenue in the aggregate.

We generate sales directly through our sales force and partners. We also identify some sales opportunities with existing customers through our customer success and professional services teams.

Our customer contracts typically range in length from twelve to 36 months. We typically invoice our customers for subscription fees annually in advance. For contracts with a two or three year term, customers sometimes elect to pay the entire multi-year subscription term in advance. Our arrangements do not contain general rights of return.

Subscription and Support Revenue. We recognize subscription and support revenue on a ratable basis over the contract term beginning on the date that our service is made available to the customer. Amounts that are invoiced are initially recorded as deferred revenue.

Table of Contents

Professional Services Revenue. We believe our professional services facilitate the sale of our subscription service to certain customers. To date, most of our professional services have consisted of document set up, XBRL tagging, and consulting to help our customers with business processes and best practices for using our platform. Our professional services are not required for customers to utilize our solution. We recognize revenue for document set ups when the service is complete and control has transferred to the customer. Revenues from XBRL tagging and consulting services are recognized as the services are performed.

Cost of Revenue

Cost of revenue consists primarily of personnel and related costs directly associated with our professional services, customer success teams and training personnel, including salaries, benefits, bonuses, and stock-based compensation; the costs of contracted third-party vendors; the costs of server usage by our customers; information technology costs; and facility costs. Costs of server usage are comprised primarily of fees paid to Amazon Web Services.

Sales and Marketing Expenses

Sales and marketing expenses consist primarily of personnel and related costs, including salaries, benefits, bonuses, commissions, travel, and stock-based compensation. Other costs included in this expense are marketing and promotional events, our annual user conference, online marketing, product marketing, information technology costs, and facility costs. We pay sales commissions for initial contracts and expansions of existing customer contracts. When the relevant amortization period is one year or less, we expense sales commissions as incurred. All other sales commissions are considered incremental costs of obtaining a contract with a customer and are deferred and amortized on a straight-line basis over a period of benefit that we have determined to be three years.

Research and Development Expenses

Research and development expenses consist primarily of personnel and related costs, including salaries, benefits, bonuses, and stock-based compensation; costs of server usage by our developers; information technology costs; and facility costs.

General and Administrative Expenses

General and administrative expenses consist primarily of personnel and related costs for our executive, finance and accounting, legal, human resources, and administrative personnel, including salaries, benefits, bonuses, and stock-based compensation; legal, accounting, and other professional service fees; other corporate expenses; information technology costs; and facility costs.

Table of Contents

Results of Operations

The following table sets forth selected consolidated statement of operations data for each of the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022

	(in thousands)
Revenue
Subscription and support	$	143,421	$	118,591	$	409,857	$	339,064
Professional services	14,754		14,258		53,529		55,008
Total revenue	158,175		132,849		463,386		394,072
Cost of revenue
Subscription and support(1)	24,864		19,235		74,080		56,683
Professional services(1)	13,491		13,184		42,297		38,846
Total cost of revenue	38,355		32,419		116,377		95,529
Gross profit	119,820		100,430		347,009		298,543
Operating expenses
Research and development(1)	41,747		38,583		130,235		113,644
Sales and marketing(1)	72,576		64,560		215,168		184,879
General and administrative(1)	21,022		27,405		86,660		75,507
Total operating expenses	135,345		130,548		432,063		374,030
Loss from operations	(15,525)		(30,118)		(85,054)		(75,487)
Interest income	7,294		1,440		15,546		2,325
Interest expense	(47,437)		(1,510)		(50,437)		(4,540)
Other (expense) income, net	(71)		964		(1,450)		1,467
Loss before provision for income taxes	(55,739)		(29,224)		(121,395)		(76,235)
Provision for income taxes	530		467		1,934		810
Net loss	$	(56,269)	$	(29,691)	$	(123,329)	$	(77,045)

(1) Stock-based compensation expense included in these line items was as follows:


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022

	(in thousands)
Cost of revenue
Subscription and support	$	1,247	$	855	$	3,732	$	2,557
Professional services	623		533		1,923		1,578
Operating expenses
Research and development	4,155		3,399		13,677		9,272
Sales and marketing	7,108		4,657		20,769		14,388
General and administrative	6,244		10,853		37,928		26,258
Total stock-based compensation expense	$	19,377	$	20,297	$	78,029	$	54,053

Table of Contents

The following table sets forth our consolidated statement of operations data as a percentage of revenue for each of the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Revenue
Subscription and support	90.7	%	89.3	%	88.4	%	86.0	%
Professional services	9.3		10.7		11.6		14.0
Total revenue	100.0		100.0		100.0		100.0
Cost of revenue
Subscription and support	15.7		14.5		16.0		14.4
Professional services	8.5		9.9		9.1		9.9
Total cost of revenue	24.2		24.4		25.1		24.3
Gross profit	75.8		75.6		74.9		75.7
Operating expenses
Research and development	26.4		29.0		28.1		28.8
Sales and marketing	45.9		48.6		46.4		46.9
General and administrative	13.3		20.6		18.7		19.2
Total operating expenses	85.6		98.2		93.2		94.9
Loss from operations	(9.8)		(22.6)		(18.3)		(19.2)
Interest income	4.6		1.1		3.4		0.6
Interest expense	(30.0)		(1.1)		(10.9)		(1.2)
Other (expense) income, net	—		0.7		(0.3)		0.4
Loss before provision for income taxes	(35.2)		(21.9)		(26.1)		(19.4)
Provision for income taxes	0.3		0.4		0.4		0.2
Net loss	(35.5)	%	(22.3)	%	(26.5)	%	(19.6)	%

Comparison of Three and Nine Months Ended September 30, 2023 and 2022

Revenue


	Three months ended September 30,					Nine months ended September 30,
	2023		2022		% Change	2023		2022		% Change

	(dollars in thousands)
Revenue
Subscription and support	$	143,421	$	118,591	20.9%	$	409,857	$	339,064	20.9%
Professional services	14,754		14,258		3.5%	53,529		55,008		(2.7)%
Total revenue	$	158,175	$	132,849	19.1%	$	463,386	$	394,072	17.6%

Table of Contents

Total revenue increased $25.3 million for the three months ended September 30, 2023 compared to the same quarter a year ago due primarily to a $24.8 million increase in subscription and support revenue. Growth in subscription and support revenue in the third quarter was attributable mainly to strong demand and continued solution expansion across our customer base. Revenue from professional services increased slightly during the three months ended September 30, 2023 compared to the same quarter a year ago. The increase in revenue from professional services was due primarily to an increase in revenue from XBRL professional services partially offset by a decrease in revenue from other services as we continue to transition consulting and other services to our partners. We expect the revenue growth rate from subscription and support to continue to outpace revenue growth from professional services on an annual basis.

Total revenue increased $69.3 million for the nine months ended September 30, 2023 compared to the same period a year ago due primarily to a $70.8 million increase in subscription and support revenue. Growth in subscription and support revenue was attributable mainly to strong demand and continued solution expansion across our customer base. Professional services revenue decreased $1.5 million during the nine months ended September 30, 2023 compared to the same period a year ago. The decrease was driven primarily by the continued transition of consulting and other services to our partners and the timing of performance of XBRL services. We expect the revenue growth rate from subscription and support to continue to outpace revenue growth from professional services on an annual basis.

Cost of Revenue


	Three months ended September 30,					Nine months ended September 30,
	2023		2022		% Change	2023		2022		% Change

	(dollars in thousands)
Cost of revenue
Subscription and support	$	24,864	$	19,235	29.3%	$	74,080	$	56,683	30.7%
Professional services	13,491		13,184		2.3%	42,297		38,846		8.9%
Total cost of revenue	$	38,355	$	32,419	18.3%	$	116,377	$	95,529	21.8%

Cost of revenue increased $5.9 million during the three months ended September 30, 2023 compared to the same quarter a year ago due primarily to $4.2 million in higher cash-based compensation and benefits costs due in part to increased headcount, $0.5 million of additional stock-based compensation, and a $0.8 million increase in the cost of cloud infrastructure services. The increases in headcount and cloud infrastructure services resulted primarily from our continued investment in and support of our platform and solutions.

Cost of revenue increased $20.8 million during the nine months ended September 30, 2023 compared to the same period a year ago due primarily to $13.4 million in higher cash-based compensation and benefits costs due in part to increased headcount, $1.5 million of additional stock-based compensation, a $1.0 million increase in travel expense, a $3.1 million increase in the cost of cloud infrastructure services, a $0.6 million increase in software expense, and a $0.5 million increase in outsourced service fees. The increases in headcount, cloud infrastructure services, software expense, and outsourced service fees resulted primarily from our continued investment in and support of our platform and solutions. The increase in travel expense was due to a modest continued return to travel.

Table of Contents

Operating Expenses


	Three months ended September 30,					Nine months ended September 30,
	2023		2022		% Change	2023		2022		% Change

	(dollars in thousands)
Operating expenses
Research and development	$	41,747	$	38,583	8.2%	$	130,235	$	113,644	14.6%
Sales and marketing	72,576		64,560		12.4%	215,168		184,879		16.4%
General and administrative	21,022		27,405		(23.3)%	86,660		75,507		14.8%
Total operating expenses	$	135,345	$	130,548	3.7%	$	432,063	$	374,030	15.5%

Research and Development

Research and development expenses increased $3.2 million during the three months ended September 30, 2023 compared to the same quarter a year ago due primarily to $2.4 million in higher cash-based compensation and benefits and $0.8 million of additional stock-based compensation. The increase in compensation was primarily driven by continued investment in our employees in support of our platform and solutions.

Research and development expenses increased $16.6 million during the nine months ended September 30, 2023 compared to the same period a year ago due primarily to $11.6 million in higher cash-based compensation and benefits, $4.4 million of additional stock-based compensation, and a $0.7 million increase in travel expense. The increase in compensation was the result of our continued investment in and support of our platform and solutions. During the first nine months of 2023, we recognized an additional $1.6 million in stock-based compensation pursuant to certain severance obligations. The increase in travel expense was primarily due to our annual internal research and development event and a modest continued return to travel.

Sales and Marketing

Sales and marketing expenses increased $8.0 million during the three months ended September 30, 2023 compared to the same quarter a year ago due primarily to $5.2 million in higher cash-based compensation and benefits and $2.5 million of additional stock-based compensation. The increase in compensation was primarily due to an increase in employee headcount and sales commissions as we continue to invest in our go-to-market activities.

Sales and marketing expenses increased $30.3 million during the nine months ended September 30, 2023 compared to the same period a year ago due primarily to $17.7 million in higher cash-based compensation and benefits, $6.4 million of additional stock-based compensation, a $3.7 million increase in travel expense, a $1.0 million increase in professional service fees, and a $0.8 million increase in software expense. During the first nine months of 2023, we recognized an additional $1.9 million in cash-based and stock-based compensation pursuant to certain severance obligations. The remaining increase in compensation was primarily due to an increase in employee headcount and sales commissions as we continue to invest in our go-to-market activities. The increases in professional service fees and software expense were the result of our continued investment in and support of our platform and solutions. The increase in travel expense was primarily due to a modest continued return to travel and our annual internal sales and marketing event which was held in person in the first half of 2023. The event was held virtually in the prior year.

Table of Contents

General and Administrative

General and administrative expenses decreased $6.4 million during the three months ended September 30, 2023 compared to the same quarter a year ago due primarily to a $0.4 million decrease in cash-based compensation and benefits, a $4.7 million decrease in stock-based compensation, and a $1.0 million decrease related to recruiting and professional service fees. The decrease in stock-based compensation during the third quarter of 2023 is primarily due to the recognition of $3.5 million in stock-based compensation pursuant to certain severance agreements during the third quarter of 2022 which did not recur in 2023. The remaining decrease in compensation was primarily due to a decrease in employee headcount.

General and administrative expenses increased $11.2 million during the nine months ended September 30, 2023 compared to the same period a year ago due primarily to $2.2 million in higher cash-based compensation and benefits, $11.6 million of additional stock-based compensation, a $0.5 million increase in public relations expense, partially offset by a $2.7 million decrease related to recruiting and professional service fees and a $1.4 million decrease in goods and service tax expense. In addition, during 2023 we recorded one-time fees of $0.6 million related to the cancellation of certain events. During the first nine months of 2023, we recognized an additional $1.4 million and $18.1 million in cash-based compensation and stock-based compensation, respectively, pursuant to certain transition agreements with former executives. Public relations expense increased during 2023 as we continue to execute on our brand strategy. The decrease in sales tax expense was related to a goods and services tax refund which is not expected to recur.

Non-Operating Income (Expenses)


	Three months ended September 30,					Nine months ended September 30,
	2023		2022		% Change	2023		2022		% Change

	(dollars in thousands)
Interest income	$	7,294	$	1,440	406.5%	$	15,546	$	2,325	568.6%
Interest expense	(47,437)		(1,510)		3041.5%	(50,437)		(4,540)		1010.9%
Other (expense) income, net	(71)		964		*	(1,450)		1,467		*

(*) Percentage is not meaningful.

Interest Income, Interest Expense and Other (Expense) Income, Net

During the three months ended September 30, 2023, interest income increased $5.9 million compared to the same quarter a year ago due primarily to an increase in our investment balance, facilitated by the issuance of our 2028 convertible notes, coupled with higher interest rates. Interest expense increased compared to the same quarter a year ago due primarily to a $45.1 million loss on induced conversion from the partial repurchase of our convertible senior notes due in 2026. Other (expense) income, net decreased $1.0 million compared to the same quarter a year ago due primarily to losses on foreign currency transactions.

During the nine months ended September 30, 2023, interest income increased $13.2 million compared to the same period a year ago due primarily to larger investment balances coupled with higher interest rates. Interest expense increased compared to the same period a year ago due primarily to a $45.1 million loss on induced conversion from the partial repurchase of convertible senior notes due in 2026. Other (expense) income, net decreased $2.9 million compared to the same period a year ago due primarily to losses on the sale of available-for-sale securities and losses on foreign currency transactions.

Table of Contents

Results of Operations for Fiscal 2022 Compared to 2021

For a comparison of our results of operations for the fiscal years ended December 31, 2022 and 2021, see "Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" of our annual report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on February 21, 2023.

Liquidity and Capital Resources

Overview of Sources and Uses of Cash

As of September 30, 2023, our principal sources of liquidity were cash, cash equivalents and marketable securities totaling $782.4 million, which were held for working capital purposes. We have financed our operations primarily through the proceeds of offerings of equity, convertible debt, and cash from operating activities. We have generated significant operating losses and negative cash flows from operating activities as reflected in our accumulated deficit and consolidated statements of cash flows. While we expect to continue to incur operating losses and may incur negative cash flows from operations in the future, we believe that current cash and cash equivalents and cash flows from operating activities will be sufficient to fund our operations for at least the next twelve months.

Convertible Debt

In August 2023, we issued $702.0 million aggregate principal amount of 1.250% convertible senior notes due 2028 (the "2028 Notes"). Proceeds from the issuance of the 2028 Notes totaled $691.1 million, net of initial purchaser discounts and issuance costs. We used $396.9 million of the net proceeds from the 2028 Notes offering to repurchase $273.8 million principal amount, together with accrued and unpaid interest thereon, of our 1.125% convertible senior notes due 2026 (the "2026 Notes") in separate and individually negotiated transactions with certain holders. As of September 30, 2023, we had outstanding debt relating to our 2026 Notes and 2028 Notes of $70.5 million and $691.4 million, with corresponding maturity dates of August 15, 2026 and August 15, 2028, respectively.

Table of Contents

Cash Flows


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022

	(in thousands)
Cash flow provided by operating activities	$	14,991	$	4,855	$	46,533	$	12,602
Cash flow used in investing activities	(109,026)		(2,632)		(182,044)		(79,246)
Cash flow provided by (used in) financing activities	301,220		3,471		300,281		(143)
Net increase (decrease) in cash and cash equivalents, net of impact of exchange rates	$	205,946	$	3,244	$	164,688	$	(70,889)

Operating Activities

For the three months ended September 30, 2023, cash provided by operating activities was $15.0 million. The primary factors affecting our operating cash flows during the period were our net loss of $56.3 million, adjusted for non-cash charges of $2.7 million for depreciation and amortization of our property and equipment and intangible assets, $19.4 million of stock-based compensation expense, $1.9 million for the accretion of premiums and discounts on marketable securities, $0.5 million for the amortization of our debt discount and issuance costs, a $45.1 million loss on induced conversion from the partial repurchase of our convertible senior notes due in 2026, and a $5.5 million net change in operating assets and liabilities. The primary drivers of the changes in operating assets and liabilities were a $15.2 million increase in accounts receivable, and a $1.6 million increase in other receivables offset by a $3.5 million decrease in prepaid expenses, a $3.1 million decrease in deferred costs, a $1.0 million decrease in other assets, a $11.1 million increase in deferred revenue, and a $3.5 million increase in accrued expenses and other liabilities. Customer growth and contract renewals for longer terms accounted for most of the increase in deferred revenue. Deferred costs decreased primarily due to the amortization of direct and incremental costs of obtaining a customer contract. The increases in accounts receivable, other receivables and accrued expenses and other liabilities as well as the decreases in prepaid expenses and other assets were attributable primarily to the timing of our billings, cash collections, and cash payments.

For the three months ended September 30, 2022, cash provided by operating activities was $4.9 million. The primary factors affecting our operating cash flows during the period were our net loss of $29.7 million, adjusted for non-cash charges of $2.7 million for depreciation and amortization of our property and equipment and intangible assets, $20.3 million of stock-based compensation expense and a $11.0 million net change in operating assets and liabilities. The primary drivers of the changes in operating assets and liabilities were a $7.9 million increase in accounts receivable, a $1.4 million increase in deferred costs, and a $1.1 million increase in other assets offset by a $3.6 million decrease in prepaid expenses, a $3.9 million increase in accounts payable and a $14.8 million increase in deferred revenue. Deferred costs increased primarily due to payments made to our sales force related to the direct and incremental costs of obtaining a customer contract. Customer growth accounted for most of the increase in deferred revenue. The increases in accounts receivable, other assets, and accounts payable as well as the decrease in prepaid expenses were attributable primarily to the timing of our billings, cash collections, and cash payments.

Table of Contents

For the nine months ended September 30, 2023, cash provided by operating activities was $46.5 million. The primary factors affecting our operating cash flows during the period were our net loss of $123.3 million, adjusted for non-cash charges of $8.4 million for depreciation and amortization of our property and equipment and intangible assets, $78.0 million of stock-based compensation expense, $4.5 million for the accretion of premiums and discounts on marketable securities, $0.7 million in realized losses on the sale of available-for-sale securities, $1.1 million for the amortization of our debt discount and issuance costs, a $45.1 million loss on induced conversion from the partial repurchase of our convertible senior notes due in 2026, and a $41.0 million net change in operating assets and liabilities. The primary drivers of the changes in operating assets and liabilities were a $4.0 million increase in prepaid expenses, a $1.8 million increase in other receivables, and a $1.3 million decrease in accounts payable offset by a $7.2 million decrease in accounts receivable, a $6.2 million decrease in deferred costs, a $1.5 million decrease in other assets, a $22.2 million increase in deferred revenue, and a $10.2 million increase in accrued expenses and other liabilities. Customer growth accounted for most of the increase in deferred revenue. Deferred costs decreased primarily due to the amortization of direct and incremental costs of obtaining a customer contract. The increases in other receivables, prepaid expenses and accrued expenses and other liabilities as well as the decreases in accounts receivable and accounts payable were attributable primarily to the timing of our billings, cash collections, and cash payments.

For the nine months ended September 30, 2022, cash provided by operating activities was $12.6 million. The primary factors affecting our operating cash flows during the period were our net loss of $77.0 million, adjusted for non-cash charges of $7.4 million for depreciation and amortization of our property and equipment and intangible assets, $54.1 million of stock-based compensation expense, $1.0 million for the amortization of our debt discount and issuance costs, $1.2 million for the amortization of premiums and discounts on marketable securities, and a $26.0 million net change in operating assets and liabilities. The primary drivers of the changes in operating assets and liabilities were a $6.2 million increase in accounts receivable, a $2.7 million increase in deferred costs, and a $1.1 million increase in other assets offset by a $0.9 million decrease in prepaid expenses, a $6.0 million increase in accounts payable, and a $28.6 million increase in deferred revenue. Deferred costs increased due primarily to payments made to our sales force related to the direct and incremental costs of obtaining a customer contract. Customer growth accounted for most of the increase in deferred revenue. The increases in accounts receivable, other assets, and accounts payable as well as the decrease in prepaid expenses were attributable primarily to the timing of our billings, cash collections, and cash payments.

Investing Activities

Cash used in investing activities of $109.0 million for the three months ended September 30, 2023 was due primarily to $145.0 million in purchases of marketable securities and $0.9 million in purchases of fixed assets partially offset by $36.9 million from maturities of marketable securities. Our capital expenditures were associated primarily with computer equipment in support of expanding our infrastructure and work force.

Cash used in investing activities of $2.6 million for the three months ended September 30, 2022 was due primarily to $41.6 million in purchases of marketable securities and $1.0 million in purchases of fixed assets partially offset by $40.1 million from maturities of marketable securities. Our capital expenditures were associated primarily with computer equipment in support of expanding our infrastructure and work force.

Cash used in investing activities of $182.0 million for the nine months ended September 30, 2023 was due primarily to $322.0 million in purchases of marketable securities and $1.7 million in purchases of fixed assets partially offset by $65.1 million from the sale of marketable securities and $76.8 million from maturities of marketable securities. Our capital expenditures were associated primarily with computer equipment in support of expanding our infrastructure and work force.

Table of Contents

Cash used in investing activities of $79.2 million for the nine months ended September 30, 2022 was due primarily to $99.2 million for the acquisition of ParsePort, $99.6 million in purchases of marketable securities, and $2.2 million in purchases of fixed assets partially offset by $106.9 million from maturities of marketable securities as well as $15.0 million from the sale of marketable securities. Our capital expenditures were associated primarily with computer equipment in support of expanding our infrastructure and work force.

Financing Activities

Cash provided by financing activities of $301.2 million for the three months ended September 30, 2023 was due primarily to $691.1 million in proceeds from the issuance of convertible senior notes due in 2028, net of issuance costs, $1.1 million in proceeds from option exercises, and $7.0 million in proceeds from shares issued in connection with our employee stock purchase plan partially offset by $396.9 million paid for the partial repurchase of our convertible senior notes due in 2026 and $1.0 million in taxes paid related to net share settlements of stock-based compensation awards.

Cash provided by financing activities of $3.5 million for the three months ended September 30, 2022 was due primarily to $0.6 million in proceeds from option exercises and $4.0 million in proceeds from shares issued in connection with our employee stock purchase plan partially offset by $0.7 million in taxes paid related to net share settlements of stock-based compensation awards.

Cash provided by financing activities of $300.3 million for the nine months ended September 30, 2023 was due primarily to $691.1 million in proceeds from the issuance of convertible senior notes due in 2028, net of issuance costs, $3.3 million in proceeds from option exercises, and $12.5 million in proceeds from shares issued in connection with our employee stock purchase plan partially offset by $396.9 million paid for the partial repurchase of our convertible senior notes due in 2026 and $9.4 million in taxes paid related to net share settlements of stock-based compensation awards.

Cash used in financing activities of $0.1 million for the nine months ended September 30, 2022 was due primarily to $10.7 million in taxes paid related to net share settlements of stock-based compensation awards and $1.3 million in principal payments on finance lease obligations partially offset by $2.6 million in proceeds from option exercises and $9.3 million in proceeds from shares issued in connection with our employee stock purchase plan.

Contractual Obligations and Commitments

There were no material changes in our contractual obligations and commitments from those disclosed in the Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on February 21, 2023.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses, income taxes and related disclosures. On an ongoing basis, we evaluate our estimates and assumptions. Our actual results may differ from these estimates under different assumptions or conditions.

During the nine months ended September 30, 2023, there were no significant changes to our critical accounting policies and estimates as described in the financial statements contained in the Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on February 21, 2023.

Table of Contents

Item 3. Quantitative and Qualitative Disclosures about Market Risk

For quantitative and qualitative disclosures about market risk, see “Item 7A., Quantitative and Qualitative Disclosures About Market Risk” of our Annual Report on Form 10-K for the year ended December 31, 2022. Our exposures to market risk have not changed materially since December 31, 2022.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q.

Based on such evaluation, our principal executive officer and principal financial officer have concluded that as of such date, our disclosure controls and procedures are designed to, and are effective to, provide assurance at a reasonable level that the information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Limitations on the Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures and internal control over financial reporting, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures and internal control over financial reporting must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Table of Contents

Part II. Other Information

Item 1. Legal Proceedings

From time to time we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We are not presently a party to any legal proceedings that in the opinion of our management, if determined adversely to us, would have a material adverse effect on our business, financial condition, operating results or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2022 Annual Report on Form 10-K, which could materially affect our business, financial condition or future results. There have been no material changes during fiscal 2023 to the risk factors that were included in the Form 10-K, other than what is set forth immediately below.

Recent events affecting the financial services industry could have an adverse impact on the Company's business operations, financial condition and results of operations.

Silicon Valley Bank and Signature Bank closed in March of 2023 which created bank-specific and broader financial institution liquidity risks and concerns. The future effect of these events on the financial services industry and broader economy are unknown and difficult to predict but could include failures of other financial institutions to which we or our customers face direct or more significant exposure, as well as other risks not yet identified. Any of these effects could have material adverse impacts on our liquidity, our current and/or projected business operations and financial condition and our results of operations.

Item 2. Unregistered Sales of Securities and Use of Proceeds

Sales of Unregistered Securities

Not applicable.

Issuer Purchases of Equity Securities

The following table provides information about purchases of shares of our Class A Common Stock during the three months ended September 30, 2023 related to shares withheld upon vesting of restricted stock units for tax withholding obligations:


Date	Total Number of Shares Purchased (1)	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Program	Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under Program
July 2023	279	$	101.66	—	—
August 2023	906	106.06		—	—
September 2023	7,787	110.38		—	—
Total	8,972	$	109.67	—	—

Table of Contents

(1) Total number of shares delivered to us by employees to satisfy the mandatory tax withholding requirement upon vesting of stock-based compensation awards.

Item 5. Other Information

Director and Officer Trading Arrangements

On September 11, 2023, Michael Hawkins, Executive Vice President of Sales, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 20,152 shares of the Company's Class A common stock until February 9, 2024.

During the three months ended September 30, 2023, no director or officer of the Company, other than what has been set forth immediately above, adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Table of Contents

Item 6. Exhibits

The following exhibits are being filed herewith or incorporated by reference herein:


Exhibit Number						Description

4.1						Indenture, dated August 17, 2023, between Workiva Inc. and U.S. Bank Trust Company, National Association, incorporated by reference from Exhibit 4.1 to the Company's Current Report on Form 8-K filed on August 17 2023.

4.2						Form of 1.25 0 % Convertible Senior Note due 2028, incorporated by reference from Exhibit 4.2 to the Company's Current Report on Form 8-K filed on August 17, 2023.
31.1						Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2						Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1						Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2						Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101						The following financial information from Workiva Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 formatted in Inline XBRL (Extensible Business Reporting Language) includes: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Comprehensive Loss, (iv) the Consolidated Statements of Changes in Stockholders Equity, (v) the Condensed Consolidated Statements of Cash Flows, and (vi) Notes to the Condensed Consolidated Financial Statements.

104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 30th day of October, 2023.


WORKIVA INC.

By:			/s/ Julie Iskow
Name:			Julie Iskow
Title:			President and Chief Executive Officer

By:			/s/ Jill Klindt
Name:			Jill Klindt
Title:			Executive Vice President, Chief Financial Officer and Treasurer

S-1

CERTIFICATION UNDER SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Julie Iskow, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Workiva Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


October 30, 2023						/s/ Julie Iskow Julie Iskow President and Chief Executive Officer (Principal Executive Officer)

CERTIFICATION UNDER SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Jill Klindt, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Workiva Inc.;

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


October 30, 2023						/s/ Jill Klindt Jill Klindt Executive Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)

CERTIFICATION UNDER SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

I, Julie Iskow, President and Chief Executive Officer of Workiva Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1.the Quarterly Report on Form 10-Q of the Company for the period ended September 30, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.



October 30, 2023						/s/ Julie Iskow Julie Iskow President and Chief Executive Officer (Principal Executive Officer)

CERTIFICATION UNDER SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

I, Jill Klindt, Executive Vice President, Chief Financial Officer, and Treasurer of Workiva Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.



October 30, 2023						/s/ Jill Klindt Jill Klindt Executive Vice President, Chief Financial Officer, and Treasurer (Principal Financial Officer)

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2023	Oct. 24, 2023
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-36773
Entity Registrant Name	WORKIVA INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-2509828
Entity Address, Address Line One	2900 University Blvd
Entity Address, City or Town	Ames
Entity Address, State or Province	IA
Entity Address, Postal Zip Code	50010
City Area Code	888
Local Phone Number	275-3125
Title of 12(b) Security	Class A common stock, par value $.001
Trading Symbol	WK
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001445305
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Class A Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		50,202,454
Class B Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		3,845,583

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 404,885	$ 240,197
Marketable securities	377,533	190,595
Accounts receivable, net of allowance for doubtful accounts of $801 and $744 at September 30, 2023 and December 31, 2022, respectively	98,861	106,316
Deferred costs	36,953	38,350
Other receivables	7,017	6,674
Prepaid expenses and other	21,902	17,957
Total current assets	947,151	600,089
Property and equipment, net	25,102	27,096
Operating lease right-of-use assets	10,228	13,932
Deferred costs, non-current	28,816	33,682
Goodwill	108,851	109,740
Intangible assets, net	23,585	28,234
Other assets	5,395	6,847
Total assets	1,149,128	819,620
Current liabilities
Accounts payable	4,909	6,174
Accrued expenses and other current liabilities	94,158	83,999
Deferred revenue	338,418	316,263
Finance lease obligations	525	504
Total current liabilities	438,010	406,940
Convertible senior notes, non-current	761,847	340,257
Deferred revenue, non-current	38,216	38,237
Other long-term liabilities	1,539	1,518
Operating lease liabilities, non-current	9,023	12,102
Finance lease obligations, non-current	14,186	14,583
Total liabilities	1,262,821	813,637
Stockholders’ (deficit) equity
Preferred stock, $0.001 par value per share, 100,000,000 shares authorized, no shares issued and outstanding	0	0
Additional paid-in-capital	541,093	537,732
Accumulated deficit	(648,445)	(525,116)
Accumulated other comprehensive loss	(6,395)	(6,686)
Total stockholders’ (deficit) equity	(113,693)	5,983
Total liabilities and stockholders’ (deficit) equity	1,149,128	819,620
Class A Common Stock
Stockholders’ (deficit) equity
Common stock	50	49
Class B Common Stock
Stockholders’ (deficit) equity
Common stock	$ 4	$ 4

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Allowance for doubtful accounts	$ 801	$ 744
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, share authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	50,173,423	48,761,804
Common stock, shares outstanding (in shares)	50,173,423	48,761,804
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, share authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	3,845,583	3,890,583
Common stock, shares outstanding (in shares)	3,845,583	3,890,583

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue
Total revenue	$ 158,175	$ 132,849	$ 463,386	$ 394,072
Cost of revenue
Total cost of revenue	38,355	32,419	116,377	95,529
Gross profit	119,820	100,430	347,009	298,543
Operating expenses
Research and development	41,747	38,583	130,235	113,644
Sales and marketing	72,576	64,560	215,168	184,879
General and administrative	21,022	27,405	86,660	75,507
Total operating expenses	135,345	130,548	432,063	374,030
Loss from operations	(15,525)	(30,118)	(85,054)	(75,487)
Interest income	7,294	1,440	15,546	2,325
Interest expense	(47,437)	(1,510)	(50,437)	(4,540)
Other (expense) income, net	(71)	964	(1,450)	1,467
Loss before provision for income taxes	(55,739)	(29,224)	(121,395)	(76,235)
Provision for income taxes	530	467	1,934	810
Net loss	$ (56,269)	$ (29,691)	$ (123,329)	$ (77,045)
Net loss per common share:
Basic (in dollars per share)	$ (1.04)	$ (0.56)	$ (2.28)	$ (1.46)
Diluted (in dollars per share)	$ (1.04)	$ (0.56)	$ (2.28)	$ (1.46)
Weighted-average common shares outstanding - basic (in shares)	54,256,941	53,081,564	53,987,791	52,844,532
Weighted-average common shares outstanding - diluted (in shares)	54,256,941	53,081,564	53,987,791	52,844,532
Subscription and support
Revenue
Total revenue	$ 143,421	$ 118,591	$ 409,857	$ 339,064
Cost of revenue
Total cost of revenue	24,864	19,235	74,080	56,683
Professional services
Revenue
Total revenue	14,754	14,258	53,529	55,008
Cost of revenue
Total cost of revenue	$ 13,491	$ 13,184	$ 42,297	$ 38,846

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (56,269)	$ (29,691)	$ (123,329)	$ (77,045)
Other comprehensive (loss) income
Foreign currency translation adjustment	(3,189)	(7,256)	(1,180)	(13,344)
Unrealized gain (loss) on available-for-sale securities	208	(619)	1,471	(3,033)
Other comprehensive (loss) income	(2,981)	(7,875)	291	(16,377)
Comprehensive loss	$ (59,250)	$ (37,566)	$ (123,038)	$ (93,422)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock (Class A and B)	Additional Paid-in-Capital	Additional Paid-in-Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning of the period (in shares) at Dec. 31, 2021			51,444,000
Beginning of the period at Dec. 31, 2021	$ 72,979	$ (40,299)	$ 51	$ 525,646	$ (58,560)	$ (288)	$ (452,430)	$ 18,261
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	15,309			15,309
Issuance of common stock upon exercise of stock options (in shares)			62,000
Issuance of common stock upon exercise of stock options	825		$ 1	824
Issuance of common stock under employee stock purchase plan (in shares)			53,000
Issuance of common stock under employee stock purchase plan	5,218			5,218
Issuance of restricted stock units (in shares)			545,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)			(73,000)
Tax withholding related to net share settlements of stock-based compensation awards	(8,570)			(8,570)
Net loss	(18,493)						(18,493)
Other comprehensive (loss) income	(1,776)					(1,776)
End of period (in shares) at Mar. 31, 2022			52,031,000
End of period at Mar. 31, 2022	25,193		$ 52	479,867		(2,064)	(452,662)
Beginning of the period (in shares) at Dec. 31, 2021			51,444,000
Beginning of the period at Dec. 31, 2021	72,979	$ (40,299)	$ 51	525,646	$ (58,560)	(288)	(452,430)	$ 18,261
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(77,045)
Other comprehensive (loss) income	(16,377)
End of period (in shares) at Sep. 30, 2022			52,495,000
End of period at Sep. 30, 2022	(5,490)		$ 53	522,336		(16,665)	(511,214)
Beginning of the period (in shares) at Mar. 31, 2022			52,031,000
Beginning of the period at Mar. 31, 2022	25,193		$ 52	479,867		(2,064)	(452,662)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	18,447			18,447
Issuance of common stock upon exercise of stock options (in shares)			76,000
Issuance of common stock upon exercise of stock options	1,145			1,145
Issuance of restricted stock units (in shares)			144,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)			(12,000)
Tax withholding related to net share settlements of stock-based compensation awards	(1,344)			(1,344)
Net loss	(28,861)						(28,861)
Other comprehensive (loss) income	(6,726)					(6,726)
End of period (in shares) at Jun. 30, 2022			52,239,000
End of period at Jun. 30, 2022	7,854		$ 52	498,115		(8,790)	(481,523)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	20,297			20,297
Issuance of common stock upon exercise of stock options (in shares)			43,000
Issuance of common stock upon exercise of stock options	625			625
Issuance of common stock under employee stock purchase plan (in shares)			79,000
Issuance of common stock under employee stock purchase plan	4,038		$ 1	4,037
Issuance of restricted stock units (in shares)			145,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)			(11,000)
Tax withholding related to net share settlements of stock-based compensation awards	(738)			(738)
Net loss	(29,691)						(29,691)
Other comprehensive (loss) income	(7,875)					(7,875)
End of period (in shares) at Sep. 30, 2022			52,495,000
End of period at Sep. 30, 2022	(5,490)		$ 53	522,336		(16,665)	(511,214)
Beginning of the period (in shares) at Dec. 31, 2022			52,652,000
Beginning of the period at Dec. 31, 2022	5,983		$ 53	537,732		(6,686)	(525,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	38,042			38,042
Issuance of common stock upon exercise of stock options (in shares)			102,000
Issuance of common stock upon exercise of stock options	1,457			1,457
Issuance of common stock under employee stock purchase plan (in shares)			107,000
Issuance of common stock under employee stock purchase plan	5,546			5,546
Issuance of restricted stock units (in shares)			449,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)			(78,000)
Tax withholding related to net share settlements of stock-based compensation awards	(7,228)			(7,228)
Net loss	(46,150)						(46,150)
Other comprehensive (loss) income	3,280					3,280
End of period (in shares) at Mar. 31, 2023			53,232,000
End of period at Mar. 31, 2023	930		$ 53	575,549		(3,406)	(571,266)
Beginning of the period (in shares) at Dec. 31, 2022			52,652,000
Beginning of the period at Dec. 31, 2022	$ 5,983		$ 53	537,732		(6,686)	(525,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	219,354
Net loss	$ (123,329)
Other comprehensive (loss) income	291
End of period (in shares) at Sep. 30, 2023			54,019,000
End of period at Sep. 30, 2023	(113,693)		$ 54	541,093		(6,395)	(648,445)
Beginning of the period (in shares) at Mar. 31, 2023			53,232,000
Beginning of the period at Mar. 31, 2023	930		$ 53	575,549		(3,406)	(571,266)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	20,610			20,610
Issuance of common stock upon exercise of stock options (in shares)			47,000
Issuance of common stock upon exercise of stock options	747		$ 1	746
Issuance of restricted stock units (in shares)			266,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)			(12,000)
Tax withholding related to net share settlements of stock-based compensation awards	(1,212)			(1,212)
Net loss	(20,910)						(20,910)
Other comprehensive (loss) income	(8)					(8)
End of period (in shares) at Jun. 30, 2023			53,533,000
End of period at Jun. 30, 2023	157		$ 54	595,693		(3,414)	(592,176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	19,377			19,377
Issuance of common stock upon exercise of stock options (in shares)			70,000
Issuance of common stock upon exercise of stock options	1,120			1,120
Issuance of common stock under employee stock purchase plan (in shares)			93,000
Issuance of common stock under employee stock purchase plan	6,967			6,967
Issuance of restricted stock units (in shares)			332,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)			(9,000)
Tax withholding related to net share settlements of stock-based compensation awards	(984)			(984)
Induced conversion of convertible senior notes	(81,080)			(81,080)
Net loss	(56,269)						(56,269)
Other comprehensive (loss) income	(2,981)					(2,981)
End of period (in shares) at Sep. 30, 2023			54,019,000
End of period at Sep. 30, 2023	$ (113,693)		$ 54	$ 541,093		$ (6,395)	$ (648,445)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities
Net loss	$ (56,269)	$ (29,691)	$ (123,329)	$ (77,045)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	2,686	2,681	8,353	7,365
Stock-based compensation expense	19,377	20,297	78,029	54,053
Provision for doubtful accounts	8	91	57	82
Realized loss on sale of available-for-sale securities, net	0	0	708	0
(Accretion) amortization of premiums and discounts on marketable securities, net	(1,930)	129	(4,530)	1,242
Amortization of issuance costs and debt discount	472	325	1,122	973
Induced conversion expense	45,144	0	45,144	0
Deferred income tax	(14)	57	(17)	(91)
Changes in assets and liabilities:
Accounts receivable	(15,234)	(7,927)	7,243	(6,190)
Deferred costs	3,116	(1,372)	6,248	(2,662)
Operating lease right-of-use asset	1,244	1,269	3,807	3,877
Other receivables	(1,556)	(527)	(1,842)	38
Prepaid expenses and other	3,452	3,593	(3,985)	870
Other assets	1,043	(1,140)	1,479	(1,105)
Accounts payable	(386)	3,931	(1,267)	5,995
Deferred revenue	11,120	14,775	22,225	28,573
Operating lease liability	(750)	(1,113)	(3,129)	(3,757)
Accrued expenses and other liabilities	3,468	(523)	10,217	384
Net cash provided by operating activities	14,991	4,855	46,533	12,602
Cash flows from investing activities
Purchase of property and equipment	(895)	(1,023)	(1,732)	(2,226)
Purchase of marketable securities	(144,989)	(41,618)	(322,008)	(99,564)
Sale of marketable securities	0	0	65,052	14,981
Maturities of marketable securities	36,906	40,071	76,811	106,857
Acquisitions, net of cash acquired	0	0	0	(99,186)
Purchase of intangible assets	(48)	(62)	(167)	(108)
Net cash used in investing activities	(109,026)	(2,632)	(182,044)	(79,246)
Cash flows from financing activities
Proceeds from option exercises	1,120	625	3,324	2,595
Taxes paid related to net share settlements of stock-based compensation awards	(984)	(738)	(9,424)	(10,652)
Proceeds from shares issued in connection with employee stock purchase plan	6,967	4,038	12,513	9,256
Proceeds from the issuance of convertible senior notes, net of issuance costs	691,113	0	691,113	0
Payments for repurchase of convertible senior notes	(396,869)	0	(396,869)	0
Principal payments on finance lease obligations	(127)	(454)	(376)	(1,342)
Net cash provided by (used in) financing activities	301,220	3,471	300,281	(143)
Effect of foreign exchange rates on cash	(1,239)	(2,450)	(82)	(4,102)
Net increase (decrease) in cash and cash equivalents	205,946	3,244	164,688	(70,889)
Cash and cash equivalents at beginning of period	198,939	226,253	240,197	300,386
Cash and cash equivalents at end of period	404,885	229,497	404,885	229,497
Supplemental cash flow disclosure
Cash paid for interest	2,160	2,152	4,509	4,535
Cash paid for income taxes, net of refunds	$ 604	$ 225	$ 2,126	$ 852

Organization and Significant Accounting Policies	9 Months Ended
Organization and Significant Accounting Policies	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Significant Accounting Policies	Organization and Significant Accounting Policies Organization Workiva Inc., a Delaware corporation, and its wholly-owned subsidiaries (the “Company” or “we” or “us”) is on a mission to power transparent reporting for a better world. We believe that consumers, employees, shareholders, and other stakeholders today expect more from business – more action, transparency, and disclosure of financial and non-financial information. We build solutions to meet that demand and streamline processes, connect data and teams, and ensure consistency – all within the Workiva platform, the world’s leading cloud platform for assured integrated reporting. Our operational headquarters are located in Ames, Iowa, with additional offices located in the United States, Europe, the Asia-Pacific region and Canada. Basis of Presentation and Principles of Consolidation The financial information presented in the accompanying unaudited condensed consolidated financial statements has been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated balance sheet data as of December 31, 2022 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting primarily of normal recurring accruals, necessary for a fair presentation of our financial position and results of operations. The operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results expected for the full year ending December 31, 2023. Seasonality affects our revenue, expenses and cash flows from operations. Revenue from professional services has been higher in the first quarter as many of our customers file their 10-K in the first calendar quarter. Our sales and marketing expense also has some degree of seasonality. With the exception of September 2020 and September 2021 when we transitioned to a virtual event, sales and marketing expense has historically been higher in the third quarter due to our annual user conference in September. In addition, the timing of the payments of cash bonuses to employees during the first and fourth calendar quarters may result in some seasonality in operating cash flow. The condensed consolidated financial information should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in this report and the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on February 21, 2023. The unaudited condensed consolidated financial statements include the accounts of Workiva Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions believed to be reasonable. These estimates include, but are not limited to, the allowance for doubtful accounts, the determination of the relative selling prices of our services, the measurement of material rights, health insurance claims incurred but not yet reported, valuation of available-for-sale marketable securities, useful lives of deferred contract costs, intangible assets and property and equipment, goodwill, income taxes, discount rates used in the valuation of right-of-use assets and lease liabilities, and certain assumptions used in the valuation of equity awards. While these estimates are based on our best knowledge of current events and actions that may affect us in the future, actual results may differ materially from these estimates. Recently Adopted Accounting Pronouncements None. New Accounting Pronouncements Not Yet Adopted None.

Supplemental Consolidated Balance Sheet Information

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Supplemental Consolidated Balance Sheet Information

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	As of September 30, 2023		As of December 31, 2022
Accrued vacation	$	15,551	$	12,939
Accrued commissions	6,083		10,841
Accrued bonuses	21,796		5,597
Accrued payroll	5,181		5,318
Estimated health insurance claims	2,573		1,841
Accrued interest	1,116		1,455
ESPP employee contributions	4,163		5,661
Customer deposits	24,932		25,520
Operating lease liabilities	4,463		5,720
Accrued other liabilities	8,300		9,107
	$	94,158	$	83,999

Cash Equivalents and Marketable Securities

9 Months Ended

Sep. 30, 2023

Investments, Debt and Equity Securities [Abstract]

Cash Equivalents and Marketable Securities

At September 30, 2023, cash equivalents and marketable securities consisted of the following (in thousands):


	Amortized Cost		Unrealized Gains		Unrealized Losses		Aggregate Fair Value
Money market funds	$	260,895	$	—	$	—	$	260,895
Commercial paper	72,852		—		—		72,852
U.S. treasury debt securities	157,080		7		(305)		156,782
U.S. government agency debt securities	61,190		—		(118)		61,072
Corporate debt securities	125,397		2		(728)		124,671
Foreign government debt securities	997		—		(16)		981
	$	678,411	$	9	$	(1,167)	$	677,253
Included in cash and cash equivalents	$	299,720	$	—	$	—	$	299,720
Included in marketable securities	$	378,691	$	9	$	(1,167)	$	377,533

At December 31, 2022, cash equivalents and marketable securities consisted of the following (in thousands):


	Amortized Cost		Unrealized Gains		Unrealized Losses		Aggregate Fair Value
Money market funds	$	182,878	$	—	$	—	$	182,878

U.S. treasury debt securities	72,151		1		(899)		71,253
Corporate debt securities	120,081		62		(1,771)		118,372
Foreign government debt securities	993		—		(23)		970
	$	376,103	$	63	$	(2,693)	$	373,473
Included in cash and cash equivalents	$	182,878	$	—	$	—	$	182,878
Included in marketable securities	$	193,225	$	63	$	(2,693)	$	190,595

The contractual maturities of the investments classified as marketable securities are as follows (in thousands):


	As of September 30, 2023
Due within one year	$	250,767
Due in one to two years	126,766

	$	377,533


	As of September 30, 2023
	Less than 12 months				12 months or greater
	Fair Value		Unrealized Loss		Fair Value		Unrealized Loss
U.S. treasury debt securities	$	90,224	$	(230)	$	6,567	$	(76)
U.S. government agency debt securities	61,072		(118)		—		—
Corporate debt securities	90,732		(463)		27,945		(264)
Foreign government debt securities	—		—		981		(16)
Total	$	242,028	$	(811)	$	35,493	$	(356)

Fair Value Measurements

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

Fair Value Measurements

Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities.

Level 3 - Inputs are unobservable inputs based on our assumptions.

Financial Assets


	Fair Value Measurements as of September 30, 2023						Fair Value Measurements as of December 31, 2022
Description	Total		Level 1		Level 2		Total		Level 1		Level 2
Money market funds	$	260,895	$	260,895	$	—	$	182,878	$	182,878	$	—
Commercial paper	72,852		—		72,852		—		—		—
U.S. treasury debt securities	156,782		—		156,782		71,253		—		71,253
U.S. government agency debt securities	61,072		—		61,072		—		—		—
Corporate debt securities	124,671		—		124,671		118,372		—		118,372
Foreign government debt securities	981		—		981		970		—		970
	$	677,253	$	260,895	$	416,358	$	373,473	$	182,878	$	190,595

Included in cash and cash equivalents	$	299,720					$	182,878
Included in marketable securities	$	377,533					$	190,595

Convertible Senior Notes

Convertible Senior Notes

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Convertible Senior Notes

The following table presents details of our convertible senior notes, which are further discussed below (original principal in thousands):

Month Issued

Maturity Date

Free Convertibility Date

Redemption Date

Original Principal (including overallotment)

Initial Conversion Rate per $1,000 Principal

Initial Conversion Price

2026 Notes

August 2019

August 15, 2026

May 15, 2026

August 21, 2023

345,000

12.4756

80.16

2028 Notes

August 2023

August 15, 2028

May 15, 2028

August 21, 2026

702,000

7.4690

133.89

The 2026 Notes and the 2028 Notes are together referred to as the "Notes".

•if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

•upon the occurrence of certain specified corporate events as set forth in the relevant indenture.

As of September 30, 2023, the remaining life of the 2026 Notes and 2028 Notes were approximately 2.8 years and 4.9 years.

Partial Repurchase of 2026 Notes

The net carrying amount of the Notes was as follows (in thousands):


	September 30, 2023				December 31, 2022
	2026 Notes		2028 Notes		2026 Notes		2028 Notes
Principal	$	71,242	$	702,000	$	345,000	$	—
Unamortized issuance costs	(778)		(10,617)		(4,743)		—
Net carrying amount	$	70,464	$	691,383	$	340,257	$	—

Interest expense related to the Notes was as follows (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Contractual interest expense	$	1,618	$	970	$	3,558	$	2,910
Amortization of issuance costs	472		325		1,122		973
Total interest expense	$	2,090	$	1,295	$	4,680	$	3,883

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation From time to time we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We evaluate the development of legal matters on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Although the results of litigation and claims cannot be predicted with certainty, we currently believe that the final outcome of any currently pending legal proceedings to which we are a party will not have a material adverse effect on our business, operating results, financial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Stock-Based Compensation

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Stock-Based Compensation

Stock-Based Compensation Expense

Stock-based compensation expense was recorded in the following cost and expense categories consistent with the respective employee or service provider’s related cash compensation (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Cost of revenue
Subscription and support	$	1,247	$	855	$	3,732	$	2,557
Professional services	623		533		1,923		1,578
Operating expenses
Research and development	4,155		3,399		13,677		9,272
Sales and marketing	7,108		4,657		20,769		14,388
General and administrative	6,244		10,853		37,928		26,258
Total	$	19,377	$	20,297	$	78,029	$	54,053

Stock Options

The following table summarizes the option activity under the Plans for the nine months ended September 30, 2023:


	Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)

Outstanding at December 31, 2022	1,509,172	$	14.57	3.2
Granted	—	—
Forfeited	(10)	13.60
Expired	—	—
Exercised	(219,354)	15.16
Outstanding at September 30, 2023	1,289,808	$	14.47	2.5

Exercisable at September 30, 2023	1,289,808	$	14.47	2.5

Restricted Stock Units and Performance Restricted Stock Units

The following table summarizes the restricted stock unit and performance restricted stock unit activity under the Plans for the nine months ended September 30, 2023:


	Number of Shares	Weighted- Average Grant Date Fair Value

Unvested at December 31, 2022	1,921,927	$	93.80
Granted	1,148,206	94.70
Forfeited	(106,570)	92.53
Vested(1)	(689,844)	86.47
Unvested at September 30, 2023	2,273,719	$	96.51

Employee Stock Purchase Plan

Revenue Recognition

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Disaggregation of Revenue

Revenues by industry are derived from leading software providers. The following table presents our revenues disaggregated by industry (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Industrials	$	23,461	$	18,810	$	68,670	$	56,398
Diversified financials	22,927		17,472		66,916		51,864
Information technology	17,041		15,283		50,925		45,418
Banks	15,951		13,871		46,554		39,943
Consumer discretionary	15,224		13,301		44,511		38,147
Healthcare	13,549		11,701		39,949		35,158
Insurance	9,725		8,161		28,031		23,683
Real estate	6,600		5,647		19,765		17,651
Energy	6,618		5,577		19,883		17,169
Utilities	5,854		5,383		17,165		16,800
Materials	5,852		5,121		17,391		15,954
Public administration	4,886		3,844		13,754		11,046
Consumer staples	4,557		4,213		13,544		12,626
Telecommunication services	4,449		3,262		12,352		9,724
Other	1,481		1,203		3,976		2,491
Total revenues	$	158,175	$	132,849	$	463,386	$	394,072

The following table presents our revenues disaggregated by type of good or service (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Subscription and support	$	143,421	$	118,591	$	409,857	$	339,064
XBRL professional services	11,555		10,634		42,719		41,844
Other services	3,199		3,624		10,810		13,164
Total revenues	$	158,175	$	132,849	$	463,386	$	394,072

Deferred Revenue

Transaction Price Allocated to the Remaining Performance ObligationsAs of September 30, 2023, we expect revenue of approximately $835.5 million to be recognized from remaining performance obligations for subscription contracts. We expect to recognize approximately $466.7 million of these remaining performance obligations over the next 12 months with the balance substantially recognized in the 24 months thereafter.

Net Loss Per Share

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

Net Loss Per Share

A reconciliation of the denominator used in the calculation of basic and diluted loss per share is as follows (in thousands, except share and per share data):


	Three months ended
	September 30, 2023				September 30, 2022
	Class A		Class B		Class A		Class B
Numerator
Net loss	$	(52,281)	$	(3,988)	$	(27,515)	$	(2,176)

Denominator
Weighted-average common shares outstanding - basic and diluted	50,411,358		3,845,583		49,190,981		3,890,583
Basic and diluted net loss per share	$	(1.04)	$	(1.04)	$	(0.56)	$	(0.56)


	Nine months ended
	September 30, 2023				September 30, 2022
	Class A		Class B		Class A		Class B
Numerator
Net loss	$	(114,522)	$	(8,807)	$	(71,310)	$	(5,735)

Denominator
Weighted-average common shares outstanding - basic and diluted	50,132,483		3,855,308		48,911,092		3,933,440
Basic and diluted net loss per share	$	(2.28)	$	(2.28)	$	(1.46)	$	(1.46)

The anti-dilutive securities excluded from the weighted-average shares used to calculate the diluted net loss per common share were as follows:


	As of
	September 30, 2023	September 30, 2022
Shares subject to outstanding common stock options	1,289,808	1,566,858
Shares subject to unvested restricted stock units and performance restricted stock units	2,273,719	1,949,563
Shares issuable pursuant to the ESPP	86,000	115,715
Shares underlying our convertible senior notes	9,547,320	4,304,082

We use the if-converted method for calculating any potential dilutive effect of our convertible senior notes on diluted net income per share, if applicable.

Intangible Assets and Goodwill

9 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill

The following table presents the components of net intangible assets (in thousands):


	As of September 30, 2023							As of December 31, 2022
	Weighted Average Useful Life (Years)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Acquired technology	4.5	$	15,613	$	(6,474)	$	9,139	$	15,705	$	(3,849)	$	11,856
Acquired customer-related	10.0	14,796		(2,284)		12,512		14,969		(1,169)		13,800
Acquired trade names	2.9	2,143		(1,506)		637		2,151		(861)		1,290
Patents	10.0	3,083		(1,786)		1,297		2,916		(1,628)		1,288
Total	7.1	$	35,635	$	(12,050)	$	23,585	$	35,741	$	(7,507)	$	28,234

As of September 30, 2023, expected remaining amortization expense of intangible assets by fiscal year is as follows (in thousands):


Remainder of 2023	$	1,520
2024	5,356
2025	4,623
2026	3,308
2027	2,040
Thereafter	6,738
Total expected amortization expense	$	23,585

The changes in the carrying amount of goodwill were as follows (in thousands):


December 31, 2022	$	109,740

Foreign currency translation adjustments	(889)
September 30, 2023	$	108,851

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net loss	$ (56,269)	$ (20,910)	$ (46,150)	$ (29,691)	$ (28,861)	$ (18,493)	$ (123,329)	$ (77,045)

Insider Trading Arrangements	3 Months Ended	9 Months Ended
Insider Trading Arrangements	Sep. 30, 2023 shares	Sep. 30, 2023 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Michael Hawkins [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On September 11, 2023, Michael Hawkins, Executive Vice President of Sales, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 20,152 shares of the Company's Class A common stock until February 9, 2024.
Name	Michael Hawkins
Title	Executive Vice President of Sales
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 11, 2023
Arrangement Duration	151 days
Aggregate Available	20,152	20,152

Organization and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	The financial information presented in the accompanying unaudited condensed consolidated financial statements has been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated balance sheet data as of December 31, 2022 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting primarily of normal recurring accruals, necessary for a fair presentation of our financial position and results of operations. The operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results expected for the full year ending December 31, 2023.
Principles of Consolidation	All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions believed to be reasonable. These estimates include, but are not limited to, the allowance for doubtful accounts, the determination of the relative selling prices of our services, the measurement of material rights, health insurance claims incurred but not yet reported, valuation of available-for-sale marketable securities, useful lives of deferred contract costs, intangible assets and property and equipment, goodwill, income taxes, discount rates used in the valuation of right-of-use assets and lease liabilities, and certain assumptions used in the valuation of equity awards. While these estimates are based on our best knowledge of current events and actions that may affect us in the future, actual results may differ materially from these estimates.
Recently Adopted Accounting Pronouncements and New Accounting Pronouncements Not Yet Adopted	None.None.
Fair Value of Financial Instruments	Cash equivalents primarily consist of AAA-rated money market funds with overnight liquidity and no stated maturities. We classified cash equivalents as Level 1 due to the short-term nature of these instruments and measured the fair value based on quoted prices in active markets for identical assets. When available, our marketable securities are valued using quoted prices for identical instruments in active markets. If we are unable to value our marketable securities using quoted prices for identical instruments in active markets, we value our investments using broker reports that utilize quoted market prices for comparable instruments. We validate, on a sample basis, the derived prices provided by the brokers by comparing their assessment of the fair values of our investments against the fair values of the portfolio balances of another third-party professional pricing service.

Supplemental Consolidated Balance Sheet Information (Tables)

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	As of September 30, 2023		As of December 31, 2022
Accrued vacation	$	15,551	$	12,939
Accrued commissions	6,083		10,841
Accrued bonuses	21,796		5,597
Accrued payroll	5,181		5,318
Estimated health insurance claims	2,573		1,841
Accrued interest	1,116		1,455
ESPP employee contributions	4,163		5,661
Customer deposits	24,932		25,520
Operating lease liabilities	4,463		5,720
Accrued other liabilities	8,300		9,107
	$	94,158	$	83,999

Cash Equivalents and Marketable Securities (Tables)

9 Months Ended

Sep. 30, 2023

Investments, Debt and Equity Securities [Abstract]

Schedule of Marketable Securities

At September 30, 2023, cash equivalents and marketable securities consisted of the following (in thousands):


	Amortized Cost		Unrealized Gains		Unrealized Losses		Aggregate Fair Value
Money market funds	$	260,895	$	—	$	—	$	260,895
Commercial paper	72,852		—		—		72,852
U.S. treasury debt securities	157,080		7		(305)		156,782
U.S. government agency debt securities	61,190		—		(118)		61,072
Corporate debt securities	125,397		2		(728)		124,671
Foreign government debt securities	997		—		(16)		981
	$	678,411	$	9	$	(1,167)	$	677,253
Included in cash and cash equivalents	$	299,720	$	—	$	—	$	299,720
Included in marketable securities	$	378,691	$	9	$	(1,167)	$	377,533

At December 31, 2022, cash equivalents and marketable securities consisted of the following (in thousands):


	Amortized Cost		Unrealized Gains		Unrealized Losses		Aggregate Fair Value
Money market funds	$	182,878	$	—	$	—	$	182,878

U.S. treasury debt securities	72,151		1		(899)		71,253
Corporate debt securities	120,081		62		(1,771)		118,372
Foreign government debt securities	993		—		(23)		970
	$	376,103	$	63	$	(2,693)	$	373,473
Included in cash and cash equivalents	$	182,878	$	—	$	—	$	182,878
Included in marketable securities	$	193,225	$	63	$	(2,693)	$	190,595

Schedule of Cash and Cash Equivalents

At September 30, 2023, cash equivalents and marketable securities consisted of the following (in thousands):


	Amortized Cost		Unrealized Gains		Unrealized Losses		Aggregate Fair Value
Money market funds	$	260,895	$	—	$	—	$	260,895
Commercial paper	72,852		—		—		72,852
U.S. treasury debt securities	157,080		7		(305)		156,782
U.S. government agency debt securities	61,190		—		(118)		61,072
Corporate debt securities	125,397		2		(728)		124,671
Foreign government debt securities	997		—		(16)		981
	$	678,411	$	9	$	(1,167)	$	677,253
Included in cash and cash equivalents	$	299,720	$	—	$	—	$	299,720
Included in marketable securities	$	378,691	$	9	$	(1,167)	$	377,533

At December 31, 2022, cash equivalents and marketable securities consisted of the following (in thousands):


	Amortized Cost		Unrealized Gains		Unrealized Losses		Aggregate Fair Value
Money market funds	$	182,878	$	—	$	—	$	182,878

U.S. treasury debt securities	72,151		1		(899)		71,253
Corporate debt securities	120,081		62		(1,771)		118,372
Foreign government debt securities	993		—		(23)		970
	$	376,103	$	63	$	(2,693)	$	373,473
Included in cash and cash equivalents	$	182,878	$	—	$	—	$	182,878
Included in marketable securities	$	193,225	$	63	$	(2,693)	$	190,595

Schedule of Investments Classified by Contractual Maturity Date

The contractual maturities of the investments classified as marketable securities are as follows (in thousands):


	As of September 30, 2023
Due within one year	$	250,767
Due in one to two years	126,766

	$	377,533

Schedule of Available-for-sale Securities, Continuous Unrealized Loss Position


	As of September 30, 2023
	Less than 12 months				12 months or greater
	Fair Value		Unrealized Loss		Fair Value		Unrealized Loss
U.S. treasury debt securities	$	90,224	$	(230)	$	6,567	$	(76)
U.S. government agency debt securities	61,072		(118)		—		—
Corporate debt securities	90,732		(463)		27,945		(264)
Foreign government debt securities	—		—		981		(16)
Total	$	242,028	$	(811)	$	35,493	$	(356)

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

Schedule of Assets Measured on Recurring Basis

The following table presents information about our assets that are measured at fair value on a recurring basis using the above input categories (in thousands):


	Fair Value Measurements as of September 30, 2023						Fair Value Measurements as of December 31, 2022
Description	Total		Level 1		Level 2		Total		Level 1		Level 2
Money market funds	$	260,895	$	260,895	$	—	$	182,878	$	182,878	$	—
Commercial paper	72,852		—		72,852		—		—		—
U.S. treasury debt securities	156,782		—		156,782		71,253		—		71,253
U.S. government agency debt securities	61,072		—		61,072		—		—		—
Corporate debt securities	124,671		—		124,671		118,372		—		118,372
Foreign government debt securities	981		—		981		970		—		970
	$	677,253	$	260,895	$	416,358	$	373,473	$	182,878	$	190,595

Included in cash and cash equivalents	$	299,720					$	182,878
Included in marketable securities	$	377,533					$	190,595

Convertible Senior Notes (Tables)

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Schedule of Convertible Debt

The following table presents details of our convertible senior notes, which are further discussed below (original principal in thousands):

Month Issued

Maturity Date

Free Convertibility Date

Redemption Date

Original Principal (including overallotment)

Initial Conversion Rate per $1,000 Principal

Initial Conversion Price

2026 Notes

August 2019

August 15, 2026

May 15, 2026

August 21, 2023

345,000

12.4756

80.16

2028 Notes

August 2023

August 15, 2028

May 15, 2028

August 21, 2026

702,000

7.4690

133.89

The net carrying amount of the Notes was as follows (in thousands):


	September 30, 2023				December 31, 2022
	2026 Notes		2028 Notes		2026 Notes		2028 Notes
Principal	$	71,242	$	702,000	$	345,000	$	—
Unamortized issuance costs	(778)		(10,617)		(4,743)		—
Net carrying amount	$	70,464	$	691,383	$	340,257	$	—

Interest expense related to the Notes was as follows (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Contractual interest expense	$	1,618	$	970	$	3,558	$	2,910
Amortization of issuance costs	472		325		1,122		973
Total interest expense	$	2,090	$	1,295	$	4,680	$	3,883

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-based Compensation Expense

Stock-based compensation expense was recorded in the following cost and expense categories consistent with the respective employee or service provider’s related cash compensation (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Cost of revenue
Subscription and support	$	1,247	$	855	$	3,732	$	2,557
Professional services	623		533		1,923		1,578
Operating expenses
Research and development	4,155		3,399		13,677		9,272
Sales and marketing	7,108		4,657		20,769		14,388
General and administrative	6,244		10,853		37,928		26,258
Total	$	19,377	$	20,297	$	78,029	$	54,053

Schedule of Stock-Option Activity

The following table summarizes the option activity under the Plans for the nine months ended September 30, 2023:


	Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)

Outstanding at December 31, 2022	1,509,172	$	14.57	3.2
Granted	—	—
Forfeited	(10)	13.60
Expired	—	—
Exercised	(219,354)	15.16
Outstanding at September 30, 2023	1,289,808	$	14.47	2.5

Exercisable at September 30, 2023	1,289,808	$	14.47	2.5

Schedule of Restricted Stock Units and Performance Restricted Stock Units Activity

The following table summarizes the restricted stock unit and performance restricted stock unit activity under the Plans for the nine months ended September 30, 2023:


	Number of Shares	Weighted- Average Grant Date Fair Value

Unvested at December 31, 2022	1,921,927	$	93.80
Granted	1,148,206	94.70
Forfeited	(106,570)	92.53
Vested(1)	(689,844)	86.47
Unvested at September 30, 2023	2,273,719	$	96.51

Revenue Recognition (Tables)

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table presents our revenues disaggregated by industry (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Industrials	$	23,461	$	18,810	$	68,670	$	56,398
Diversified financials	22,927		17,472		66,916		51,864
Information technology	17,041		15,283		50,925		45,418
Banks	15,951		13,871		46,554		39,943
Consumer discretionary	15,224		13,301		44,511		38,147
Healthcare	13,549		11,701		39,949		35,158
Insurance	9,725		8,161		28,031		23,683
Real estate	6,600		5,647		19,765		17,651
Energy	6,618		5,577		19,883		17,169
Utilities	5,854		5,383		17,165		16,800
Materials	5,852		5,121		17,391		15,954
Public administration	4,886		3,844		13,754		11,046
Consumer staples	4,557		4,213		13,544		12,626
Telecommunication services	4,449		3,262		12,352		9,724
Other	1,481		1,203		3,976		2,491
Total revenues	$	158,175	$	132,849	$	463,386	$	394,072

The following table presents our revenues disaggregated by type of good or service (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Subscription and support	$	143,421	$	118,591	$	409,857	$	339,064
XBRL professional services	11,555		10,634		42,719		41,844
Other services	3,199		3,624		10,810		13,164
Total revenues	$	158,175	$	132,849	$	463,386	$	394,072

Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

A reconciliation of the denominator used in the calculation of basic and diluted loss per share is as follows (in thousands, except share and per share data):


	Three months ended
	September 30, 2023				September 30, 2022
	Class A		Class B		Class A		Class B
Numerator
Net loss	$	(52,281)	$	(3,988)	$	(27,515)	$	(2,176)

Denominator
Weighted-average common shares outstanding - basic and diluted	50,411,358		3,845,583		49,190,981		3,890,583
Basic and diluted net loss per share	$	(1.04)	$	(1.04)	$	(0.56)	$	(0.56)


	Nine months ended
	September 30, 2023				September 30, 2022
	Class A		Class B		Class A		Class B
Numerator
Net loss	$	(114,522)	$	(8,807)	$	(71,310)	$	(5,735)

Denominator
Weighted-average common shares outstanding - basic and diluted	50,132,483		3,855,308		48,911,092		3,933,440
Basic and diluted net loss per share	$	(2.28)	$	(2.28)	$	(1.46)	$	(1.46)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The anti-dilutive securities excluded from the weighted-average shares used to calculate the diluted net loss per common share were as follows:


	As of
	September 30, 2023	September 30, 2022
Shares subject to outstanding common stock options	1,289,808	1,566,858
Shares subject to unvested restricted stock units and performance restricted stock units	2,273,719	1,949,563
Shares issuable pursuant to the ESPP	86,000	115,715
Shares underlying our convertible senior notes	9,547,320	4,304,082

Intangible Assets and Goodwill (Tables)

9 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Intangible Assets

The following table presents the components of net intangible assets (in thousands):


	As of September 30, 2023							As of December 31, 2022
	Weighted Average Useful Life (Years)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Acquired technology	4.5	$	15,613	$	(6,474)	$	9,139	$	15,705	$	(3,849)	$	11,856
Acquired customer-related	10.0	14,796		(2,284)		12,512		14,969		(1,169)		13,800
Acquired trade names	2.9	2,143		(1,506)		637		2,151		(861)		1,290
Patents	10.0	3,083		(1,786)		1,297		2,916		(1,628)		1,288
Total	7.1	$	35,635	$	(12,050)	$	23,585	$	35,741	$	(7,507)	$	28,234

Schedule of Expected Amortization Expense of Intangible Assets

As of September 30, 2023, expected remaining amortization expense of intangible assets by fiscal year is as follows (in thousands):


Remainder of 2023	$	1,520
2024	5,356
2025	4,623
2026	3,308
2027	2,040
Thereafter	6,738
Total expected amortization expense	$	23,585

Schedule of the Changes in the Carrying Amount of Goodwill

The changes in the carrying amount of goodwill were as follows (in thousands):


December 31, 2022	$	109,740

Foreign currency translation adjustments	(889)
September 30, 2023	$	108,851

Supplemental Consolidated Balance Sheet Information (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Accrued Expenses and Other Current Liabilities
Accrued vacation	$ 15,551	$ 12,939
Accrued commissions	6,083	10,841
Accrued bonuses	21,796	5,597
Accrued payroll	5,181	5,318
Estimated health insurance claims	2,573	1,841
Accrued interest	1,116	1,455
ESPP employee contributions	4,163	5,661
Customer deposits	24,932	25,520
Operating lease liabilities	4,463	5,720
Accrued other liabilities	8,300	9,107
Accrued expenses and other current liabilities	$ 94,158	$ 83,999

Cash Equivalents and Marketable Securities - Schedule of Marketable Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	$ 404,885	$ 240,197
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	378,691	193,225
Marketable securities, unrealized gains	9	63
Marketable securities, unrealized losses	(1,167)	(2,693)
Marketable securities, aggregate fair value	377,533	190,595
Cash and cash equivalents and available-for-sale securities, amortized cost	678,411	376,103
Cash and cash equivalents and marketable securities, aggregate fair value	677,253	373,473
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	72,852
Marketable securities, unrealized gains	0
Marketable securities, unrealized losses	0
Marketable securities, aggregate fair value	72,852
U.S. treasury debt securities
Debt Securities, Available-for-sale [Line Items]
Marketable securities, unrealized gains	7	1
Marketable securities, unrealized losses	(305)	(899)
Cash and cash equivalents and available-for-sale securities, amortized cost	157,080	72,151
Cash and cash equivalents and marketable securities, aggregate fair value	156,782	71,253
U.S. government agency debt securities
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	61,190
Marketable securities, unrealized gains	0
Marketable securities, unrealized losses	(118)
Marketable securities, aggregate fair value	61,072
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	125,397	120,081
Marketable securities, unrealized gains	2	62
Marketable securities, unrealized losses	(728)	(1,771)
Marketable securities, aggregate fair value	124,671	118,372
Foreign government debt securities
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	997	993
Marketable securities, unrealized gains	0	0
Marketable securities, unrealized losses	(16)	(23)
Marketable securities, aggregate fair value	981	970
Money market funds
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	260,895	182,878
Cash and cash equivalents, aggregate fair value	260,895	182,878
Cash Equivalents
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	299,720	182,878
Cash and cash equivalents, aggregate fair value	$ 299,720	$ 182,878

Cash Equivalents and Marketable Securities - Schedule of Contractual Maturities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Due within one year	$ 250,767
Due in one to two years	126,766
Marketable securities	$ 377,533	$ 190,595

Cash Equivalents and Marketable Securities - Continuous Unrealized Loss Position (Details) $ in Thousands	Sep. 30, 2023 USD ($)
Fair Value
Less than 12 months	$ 242,028
12 months or greater	35,493
Unrealized Loss
Less than 12 months	(811)
12 months or greater	(356)
U.S. treasury debt securities
Fair Value
Less than 12 months	90,224
12 months or greater	6,567
Unrealized Loss
Less than 12 months	(230)
12 months or greater	(76)
U.S. government agency debt securities
Fair Value
Less than 12 months	61,072
12 months or greater	0
Unrealized Loss
Less than 12 months	(118)
12 months or greater	0
Corporate debt securities
Fair Value
Less than 12 months	90,732
12 months or greater	27,945
Unrealized Loss
Less than 12 months	(463)
12 months or greater	(264)
Foreign government debt securities
Fair Value
Less than 12 months	0
12 months or greater	981
Unrealized Loss
Less than 12 months	0
12 months or greater	$ (16)

Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 377,533	$ 190,595
Cash and cash equivalents and marketable securities	677,253	373,473
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	72,852
U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents and marketable securities	156,782	71,253
U.S. government agency debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	61,072
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	124,671	118,372
Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	981	970
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	260,895	182,878
Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	299,720	182,878
Level 2 \| 2026 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of convertible debt	97,700
Level 2 \| 2028 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of convertible debt	689,700
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	377,533	190,595
Total assets measured at fair value	677,253	373,473
Recurring \| Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	72,852	0
Recurring \| U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents and marketable securities	156,782	71,253
Recurring \| U.S. government agency debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	61,072	0
Recurring \| Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	124,671	118,372
Recurring \| Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	981	970
Recurring \| Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	260,895	182,878
Recurring \| Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	299,720	182,878
Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	260,895	182,878
Recurring \| Level 1 \| Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring \| Level 1 \| U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents and marketable securities	0	0
Recurring \| Level 1 \| U.S. government agency debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring \| Level 1 \| Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring \| Level 1 \| Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring \| Level 1 \| Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	260,895	182,878
Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	416,358	190,595
Recurring \| Level 2 \| Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	72,852	0
Recurring \| Level 2 \| U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents and marketable securities	156,782	71,253
Recurring \| Level 2 \| U.S. government agency debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	61,072	0
Recurring \| Level 2 \| Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	124,671	118,372
Recurring \| Level 2 \| Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	981	970
Recurring \| Level 2 \| Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	$ 0	$ 0

Convertible Senior Notes - Summary of Convertible Debt (Details) - Convertible debt	1 Months Ended
	Aug. 31, 2023 USD ($) $ / shares	Aug. 31, 2019 USD ($) $ / shares
2026 Notes
Debt Instrument [Line Items]
Original Principal (including overallotment) \| $		$ 345,000,000
Initial Conversion Rate		0.0124756
Initial Conversion Price (in dollars per share) \| $ / shares		$ 80.16
2028 Notes
Debt Instrument [Line Items]
Original Principal (including overallotment) \| $	$ 702,000,000
Initial Conversion Rate	0.007469
Initial Conversion Price (in dollars per share) \| $ / shares	$ 133.89

Convertible Senior Notes - Narrative (Details)	1 Months Ended		3 Months Ended		9 Months Ended
Convertible Senior Notes - Narrative (Details)	Aug. 31, 2023 USD ($) day $ / shares	Aug. 31, 2019 USD ($)	Sep. 30, 2023 USD ($) $ / shares	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) $ / shares	Sep. 30, 2022 USD ($)	Dec. 31, 2022 $ / shares
Debt Instrument [Line Items]
Proceeds from the issuance of convertible senior notes			$ 691,113,000	$ 0	$ 691,113,000	$ 0
Payments for repurchase of convertible senior notes			396,869,000	0	396,869,000	0
Induced conversion expense			45,144,000	$ 0	$ 45,144,000	$ 0
Induced conversion of convertible senior notes recorded in additional-paid-in capital			$ 81,080,000
Class A Common Stock
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) \| $ / shares	$ 0.001		$ 0.001		$ 0.001		$ 0.001
Convertible debt \| Debt Conversion Terms, One
Debt Instrument [Line Items]
Threshold number of trading days (day) \| day	20
Threshold number of consecutive trading days (day) \| day	30
Threshold percentage of stock price trigger	130.00%
Redemption price, percentage	100.00%
Convertible debt \| Debt Conversion Terms, Two
Debt Instrument [Line Items]
Threshold number of trading days (day) \| day	5
Threshold number of consecutive trading days (day) \| day	10
Threshold percentage of stock trading price	98.00%
Convertible debt \| 2026 Notes
Debt Instrument [Line Items]
Face amount of debt issued		$ 345,000,000
Stated interest percentage		1.125%
Proceeds from the issuance of convertible senior notes		$ 335,900,000
Effective interest percentage			1.50%		1.50%
Remaining life of debt instrument					2 years 9 months 18 days
Payments for repurchase of convertible senior notes	$ 396,900,000
Principal amount of debt repurchased	273,800,000
Fair value of debt repurchased	351,800,000
Induced conversion expense	45,100,000
Induced conversion of convertible senior notes recorded in additional-paid-in capital	81,100,000
Debt issuance costs recorded in additional-paid-in capital upon induced conversion of convertible senior notes,	3,100,000
Convertible debt \| 2026 Notes, over-allotment option
Debt Instrument [Line Items]
Face amount of debt issued		$ 45,000,000
Convertible debt \| 2028 Notes
Debt Instrument [Line Items]
Face amount of debt issued	$ 702,000,000
Stated interest percentage	1.25%
Proceeds from the issuance of convertible senior notes	$ 691,100,000
Effective interest percentage			1.60%		1.60%
Remaining life of debt instrument					4 years 10 months 24 days
Convertible debt \| 2028 Notes, over-allotment option
Debt Instrument [Line Items]
Face amount of debt issued	77,000,000
Maximum face amount for over-allotment option	$ 100,000,000

Convertible Senior Notes - Net Carrying Amount of Convertible Debt (Details) - Convertible debt - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
2026 Notes
Debt Instrument [Line Items]
Principal	$ 71,242	$ 345,000
Unamortized issuance costs	(778)	(4,743)
Net carrying amount	70,464	340,257
2028 Notes
Debt Instrument [Line Items]
Principal	702,000	0
Unamortized issuance costs	(10,617)	0
Net carrying amount	$ 691,383	$ 0

Convertible Senior Notes - Summary of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Debt Disclosure [Abstract]
Contractual interest expense	$ 1,618	$ 970	$ 3,558	$ 2,910
Amortization of issuance costs	472	325	1,122	973
Total interest expense	$ 2,090	$ 1,295	$ 4,680	$ 3,883

Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 19,377	$ 20,297	$ 78,029	$ 54,053
Former executives who retired
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense			18,100
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	4,155	3,399	13,677	9,272
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	7,108	4,657	20,769	14,388
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	6,244	10,853	37,928	26,258
Subscription and support \| Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	1,247	855	3,732	2,557
Professional services \| Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 623	$ 533	$ 1,923	$ 1,578

Stock-Based Compensation - Stock Options (Details)	9 Months Ended	12 Months Ended
Stock-Based Compensation - Stock Options (Details)	Sep. 30, 2023 $ / shares shares	Dec. 31, 2022 $ / shares shares
Options (in shares):
Outstanding beginning of the period (in shares) \| shares	1,509,172
Granted (in shares) \| shares	0
Forfeited (in shares) \| shares	(10)
Expired (in shares) \| shares	0
Exercised (in shares) \| shares	(219,354)
Outstanding end of the period (in shares) \| shares	1,289,808	1,509,172
Exercisable (in shares) \| shares	1,289,808
Weighted-Average Exercise Price (in dollars per share):
Outstanding beginning of the period (in dollars per share) \| $ / shares	$ 14.57
Granted (in dollars per share) \| $ / shares	0
Forfeited (in dollars per share) \| $ / shares	13.60
Expired (in dollars per share) \| $ / shares	0
Exercised (in dollars per share) \| $ / shares	15.16
Outstanding end of the period (in dollars per share) \| $ / shares	14.47	$ 14.57
Exercisable (in dollars per share) \| $ / shares	$ 14.47
Outstanding, weighted-average remaining contractual term (years)	2 years 6 months	3 years 2 months 12 days
Exercisable, weighted-average remaining contractual term (years)	2 years 6 months

Stock-Based Compensation - Restricted Stock Units and Performance Restricted Stock Units (Details)	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Shares subject to unvested restricted stock units and performance restricted stock units
Number of Shares (in shares)
Unvested at beginning of period (in shares)	1,921,927
Granted (in shares)	1,148,206
Forfeited (in shares)	(106,570)
Vested (in shares)	(689,844)
Unvested at end of period (in shares)	2,273,719
Weighted- Average Grant Date Fair Value (in dollars per share)
Unvested at beginning of period (in dollars per share) \| $ / shares	$ 93.80
Granted (in dollars per share) \| $ / shares	94.70
Forfeited (in dollars per share) \| $ / shares	92.53
Vested (in dollars per share) \| $ / shares	86.47
Unvested at end of period (in dollars per share) \| $ / shares	$ 96.51
Restricted stock units
Weighted- Average Grant Date Fair Value (in dollars per share)
Number of vested shares recipient elected to defer settlement (in shares)	2,925
Number of vested shares recipients elected to defer settlement, released during period (in shares)	359,812

Stock-Based Compensation - Employee Stock Purchase Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from shares issued in connection with employee stock purchase plan	$ 6,967	$ 4,038	$ 12,513	$ 9,256
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	$ 1,300		$ 1,300
Unrecognized compensation expense, period for recognition (years)			3 months 18 days
Class A Common Stock \| Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued during period (in shares)			200,436
Shares issued during period, weighted average price per share (in dollars per share)			$ 62.43
Proceeds from shares issued in connection with employee stock purchase plan			$ 12,500

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 158,175	$ 132,849	$ 463,386	$ 394,072
Subscription and support
Disaggregation of Revenue [Line Items]
Total revenue	143,421	118,591	409,857	339,064
XBRL professional services
Disaggregation of Revenue [Line Items]
Total revenue	11,555	10,634	42,719	41,844
Other services
Disaggregation of Revenue [Line Items]
Total revenue	3,199	3,624	10,810	13,164
Industrials
Disaggregation of Revenue [Line Items]
Total revenue	23,461	18,810	68,670	56,398
Diversified financials
Disaggregation of Revenue [Line Items]
Total revenue	22,927	17,472	66,916	51,864
Information technology
Disaggregation of Revenue [Line Items]
Total revenue	17,041	15,283	50,925	45,418
Banks
Disaggregation of Revenue [Line Items]
Total revenue	15,951	13,871	46,554	39,943
Consumer discretionary
Disaggregation of Revenue [Line Items]
Total revenue	15,224	13,301	44,511	38,147
Healthcare
Disaggregation of Revenue [Line Items]
Total revenue	13,549	11,701	39,949	35,158
Insurance
Disaggregation of Revenue [Line Items]
Total revenue	9,725	8,161	28,031	23,683
Real estate
Disaggregation of Revenue [Line Items]
Total revenue	6,600	5,647	19,765	17,651
Energy
Disaggregation of Revenue [Line Items]
Total revenue	6,618	5,577	19,883	17,169
Utilities
Disaggregation of Revenue [Line Items]
Total revenue	5,854	5,383	17,165	16,800
Materials
Disaggregation of Revenue [Line Items]
Total revenue	5,852	5,121	17,391	15,954
Public administration
Disaggregation of Revenue [Line Items]
Total revenue	4,886	3,844	13,754	11,046
Consumer staples
Disaggregation of Revenue [Line Items]
Total revenue	4,557	4,213	13,544	12,626
Telecommunication services
Disaggregation of Revenue [Line Items]
Total revenue	4,449	3,262	12,352	9,724
Other
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,481	$ 1,203	$ 3,976	$ 2,491

Revenue Recognition - Deferred Revenue and Transaction Price Allocated to the Remaining Performance Obligations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized	$ 129.9	$ 107.7	$ 277.8	$ 224.6
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized	835.5		835.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized	$ 466.7		$ 466.7
Expected period of recognition	12 months		12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected period of recognition	24 months		24 months

Net Loss Per Share - Earnings Per Share Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Denominator
Weighted-average common shares outstanding - basic (in shares)	54,256,941	53,081,564	53,987,791	52,844,532
Weighted-average common shares outstanding - diluted (in shares)	54,256,941	53,081,564	53,987,791	52,844,532
Basic net loss per share (in dollars per share)	$ (1.04)	$ (0.56)	$ (2.28)	$ (1.46)
Diluted net loss per share (in dollars per share)	$ (1.04)	$ (0.56)	$ (2.28)	$ (1.46)
Class A Common Stock
Numerator
Net loss, basic	$ (52,281)	$ (27,515)	$ (114,522)	$ (71,310)
Net loss, diluted	$ (52,281)	$ (27,515)	$ (114,522)	$ (71,310)
Denominator
Weighted-average common shares outstanding - basic (in shares)	50,411,358	49,190,981	50,132,483	48,911,092
Weighted-average common shares outstanding - diluted (in shares)	50,411,358	49,190,981	50,132,483	48,911,092
Basic net loss per share (in dollars per share)	$ (1.04)	$ (0.56)	$ (2.28)	$ (1.46)
Diluted net loss per share (in dollars per share)	$ (1.04)	$ (0.56)	$ (2.28)	$ (1.46)
Class B Common Stock
Numerator
Net loss, basic	$ (3,988)	$ (2,176)	$ (8,807)	$ (5,735)
Net loss, diluted	$ (3,988)	$ (2,176)	$ (8,807)	$ (5,735)
Denominator
Weighted-average common shares outstanding - basic (in shares)	3,845,583	3,890,583	3,855,308	3,933,440
Weighted-average common shares outstanding - diluted (in shares)	3,845,583	3,890,583	3,855,308	3,933,440
Basic net loss per share (in dollars per share)	$ (1.04)	$ (0.56)	$ (2.28)	$ (1.46)
Diluted net loss per share (in dollars per share)	$ (1.04)	$ (0.56)	$ (2.28)	$ (1.46)

Net Loss Per Share - Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Shares subject to outstanding common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,289,808	1,566,858
Shares subject to unvested restricted stock units and performance restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,273,719	1,949,563
Shares issuable pursuant to the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	86,000	115,715
Shares underlying our convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	9,547,320	4,304,082

Intangible Assets and Goodwill - Intangible Asset Components (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	7 years 1 month 6 days
Gross Carrying Amount	$ 35,635	$ 35,741
Accumulated Amortization	(12,050)	(7,507)
Net Carrying Amount	$ 23,585	28,234
Acquired technology
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	4 years 6 months
Gross Carrying Amount	$ 15,613	15,705
Accumulated Amortization	(6,474)	(3,849)
Net Carrying Amount	$ 9,139	11,856
Acquired customer-related
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	10 years
Gross Carrying Amount	$ 14,796	14,969
Accumulated Amortization	(2,284)	(1,169)
Net Carrying Amount	$ 12,512	13,800
Acquired trade names
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	2 years 10 months 24 days
Gross Carrying Amount	$ 2,143	2,151
Accumulated Amortization	(1,506)	(861)
Net Carrying Amount	$ 637	1,290
Patents
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	10 years
Gross Carrying Amount	$ 3,083	2,916
Accumulated Amortization	(1,786)	(1,628)
Net Carrying Amount	$ 1,297	$ 1,288

Intangible Assets and Goodwill - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense related to intangible assets	$ 1.5	$ 1.5	$ 4.6	$ 3.8

Intangible Assets and Goodwill - Amortization of Intangible Assets by Fiscal Year (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2023	$ 1,520
2024	5,356
2025	4,623
2026	3,308
2027	2,040
Thereafter	6,738
Net Carrying Amount	$ 23,585	$ 28,234

Intangible Assets and Goodwill - Goodwill Activity (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 109,740
Foreign currency translation adjustments	(889)
Goodwill, ending balance	$ 108,851

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2020-06 [Member]

Workiva (NYSE:WK)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Workiva (NYSE:WK)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

WK Workiva Inc

News Workiva Inc

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

WK Workiva Inc

News Workiva Inc

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen